☰

Mark A. Moore, Ph.D. - Publications

Affiliations: 
2003 The University of Tennessee, Knoxville, TN, United States 
Tree Info Similar researchers PubMed Report error

2/481 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tasso AF, Pérez NA, Moore M, Griffo R, Nash MR. HYPNOTIC RESPONSIVENESS AND NONHYPNOTIC SUGGESTIBILITY: The International Journal of Clinical and Experimental Hypnosis. 68: 38-67. PMID 31914365 DOI: 10.1080/00207144.2020.1685330  0.525
2008 Borckardt JJ, Nash MR, Murphy MD, Moore M, Shaw D, O'Neil P. Clinical practice as natural laboratory for psychotherapy research: a guide to case-based time-series analysis. The American Psychologist. 63: 77-95. PMID 18284277 DOI: 10.1037/0003-066X.63.2.77  0.53
Low-probability matches (unlikely to be authored by this person)
1989 Laver J, Moore MA. Clinical use of recombinant human hematopoietic growth factors. Journal of the National Cancer Institute. 81: 1370-82. PMID 2674457 DOI: 10.1093/jnci/81.18.1370  0.274
1985 Gabrilove J, Welte K, Lu L, Castro-Malaspina H, Moore M. Constitutive production of leukemia differentiation, colony- stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor Blood. 66: 407-415. DOI: 10.1182/BLOOD.V66.2.407.407  0.239
1978 Moore MA. The role of factors in differentiation of non-erythroid cells The Symposium / the Society For Developmental Biology. Society For Developmental Biology. Symposium. 181-188. PMID 306137 DOI: 10.1016/B978-0-12-612981-6.50016-8  0.235
1991 Moore MA. The clinical use of colony stimulating factors. Annual Review of Immunology. 9: 159-91. PMID 1910675 DOI: 10.1146/ANNUREV.IY.09.040191.001111  0.225
1990 Moore MA, Muench MO, Warren DJ, Laver J. Cytokine networks involved in the regulation of haemopoietic stem cell proliferation and differentiation. Ciba Foundation Symposium. 148: 43-58; discussion 58. PMID 2180648 DOI: 10.1002/9780470513880.CH4  0.223
1979 Kurland JI, Pelus LM, Ralph P, Bockman RS, Moore MA. Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proceedings of the National Academy of Sciences of the United States of America. 76: 2326-30. PMID 313054 DOI: 10.1073/pnas.76.5.2326  0.216
1986 Gabrilove JL, Welte K, Harris P, Platzer E, Lu L, Levi E, Mertelsmann R, Moore MA. Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637. Proceedings of the National Academy of Sciences of the United States of America. 83: 2478-82. PMID 3458209 DOI: 10.1073/PNAS.83.8.2478  0.211
1988 Ottmann OG, Welte K, Souza LM, Moore MA. Proliferative effects of a recombinant human granulocyte colony-stimulating factor (rG-CSF) on highly enriched hematopoietic progenitor cells. Haematology and Blood Transfusion. 31: 244-7. PMID 2450817 DOI: 10.1007/978-3-642-72624-8_50  0.211
1981 Mertelsmann R, Gillis S, Steinmann G, Ralph P, Stiehm M, Koziner B, Moore MA. T-cell growth factor (interleukin 2) and terminal transferase activity in human leukemias and lymphoblastic cell lines. Blut. 43: 99-103. PMID 6942897 DOI: 10.1007/BF00320468  0.207
1992 Moore M. Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it? [editorial; comment] Blood. 80: 3-7. DOI: 10.1182/BLOOD.V80.1.3.BLOODJOURNAL8013  0.207
1992 Moore M. Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it? [editorial; comment] Blood. 80: 3-7. DOI: 10.1182/blood.v80.1.3.3  0.207
2018 Nelson CJ, Saracino RM, Roth AJ, Harvey E, Martin A, Moore M, Marcone D, Poppito SR, Holland J. Cancer and Aging: Reflections for Elders (CARE): A Pilot Randomized Controlled Trial of a Psychotherapy Intervention for Older Adults with Cancer. Psycho-Oncology. PMID 30296337 DOI: 10.1002/Pon.4907  0.206
1990 Moore MA. Hematopoietic growth factors in cancer. Cancer. 65: 836-44. PMID 2406005 DOI: 10.1002/1097-0142(19900201)65:3+<836::AID-CNCR2820651331>3.0.CO;2-X  0.206
1985 Yung YP, Moore MA. Mast-cell growth factor: its role in mast-cell differentiation, proliferation, and maturation. Contemporary Topics in Molecular Immunology. 10: 147-79. PMID 3920000 DOI: 10.1007/978-1-4684-4838-2_6  0.201
2005 Schuringa JJ, Wu K, Morrone G, Moore MA. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo. Stem Cells (Dayton, Ohio). 22: 1191-204. PMID 15579639 DOI: 10.1634/stemcells.2004-0033  0.201
1987 Welte K, Bonilla MA, Gillio AP, Boone TC, Potter GK, Gabrilove JL, Moore MA, O'Reilly RJ, Souza LM. Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. The Journal of Experimental Medicine. 165: 941-8. PMID 3494094 DOI: 10.1084/Jem.165.4.941  0.199
2000 Möhle R, Rafii S, Moore MA. The role of endothelium in the regulation of hematopoietic stem cell migration. Stem Cells (Dayton, Ohio). 159-65. PMID 11012158 DOI: 10.1002/Stem.5530160819  0.198
1991 Moore MA. The future of cytokine combination therapy. Cancer. 67: 2718-26. PMID 2015575 DOI: 10.1002/1097-0142(19910515)67:10+<2718::AID-CNCR2820671709>3.0.CO;2-3  0.196
1986 Platzer E, Welte K, Gabrilove JL, Lu L, Harris P, Mertelsmann R, Moore MA. Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. The Journal of Experimental Medicine. 162: 1788-801. PMID 2999287 DOI: 10.1084/JEM.162.6.1788  0.196
1995 Rafii S, Shapiro F, Pettengell R, Ferris B, Nachman R, Moore M, Asch A. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors Blood. 86: 3353-3363. DOI: 10.1182/Blood.V86.9.3353.Bloodjournal8693353  0.195
1989 Moore MA. Interactions between hematopoietic growth factors: the clinical role of combination biotherapy Hamatologie Und Bluttransfusion. 32: 11-21. PMID 2483146 DOI: 10.1007/978-3-642-74621-5_2  0.195
2010 Moore M. Steven Tuber: Attachment, Play, and Authenticity: A Winnicott Primer The American Journal of Psychoanalysis. 70: 313-316. DOI: 10.1057/Ajp.2010.17  0.194
1990 Laver J, Duncan E, Abboud M, Gasparetto C, Sahdev I, Warren D, Bussel J, Auld P, O'Reilly RJ, Moore MA. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. The Journal of Pediatrics. 116: 627-632. PMID 1690796 DOI: 10.1016/S0022-3476(05)81617-8  0.194
1985 Welte K, Platzer E, Gabrilove JL, Lu L, Levi E, Polivka A, Mertelsmann R, Moore MA. Purification to apparent homogeneity and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Haematology and Blood Transfusion. 29: 398-401. PMID 3875526 DOI: 10.1007/978-3-642-70385-0_82  0.194
1981 Castro-Malaspina H, Rabellino E, Yen A, Nachman R, Moore M. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts Blood. 57: 781-787. DOI: 10.1182/blood.V57.4.781.bloodjournal574781  0.193
1981 Castro-Malaspina H, Rabellino E, Yen A, Nachman R, Moore M. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts Blood. 57: 781-787. DOI: 10.1182/blood.v57.4.781.781  0.192
2004 Bond HM, Mesuraca M, Carbone E, Bonelli P, Agosti V, Amodio N, De Rosa G, Di Nicola M, Gianni AM, Moore MA, Hata A, Grieco M, Morrone G, Venuta S. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood. 103: 2062-70. PMID 14630787 DOI: 10.1182/Blood-2003-07-2388  0.192
2003 Rafii S, Avecilla S, Shmelkov S, Shido K, Tejada R, Moore MA, Heissig B, Hattori K. Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment. Annals of the New York Academy of Sciences. 996: 49-60. PMID 12799282 DOI: 10.1111/J.1749-6632.2003.Tb03232.X  0.191
2004 Weisel KC, Gao Y, Shieh J, Kanz L, Moore MA. Genetic and Functional Characterization of Isolated Stromal Cell Lines from the Aorta-Gonado-Mesonephros (AGM)-Region. Blood. 104: 2328-2328. DOI: 10.1182/BLOOD.V104.11.2328.2328  0.19
1996 Szabolcs P, Avigan D, Gezelter S, Ciocon DH, Moore MA, Steinman RM, Young JW. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood. 87: 4520-30. PMID 8639819 DOI: 10.1182/Blood.V87.11.4520.Bloodjournal87114520  0.189
1990 Moore MA, Stolfi RL, Martin DS. Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil. Journal of the National Cancer Institute. 82: 1031-7. PMID 1693405 DOI: 10.1093/JNCI/82.12.1031  0.188
1983 Maurer DH, Welte K, Mertelsmann R, Moore MA, Ralph P. Lymphokine factors inducing IgG production in human B-cell line ARH-77 and stimulatory effects of phorbol ester tumor promoter. Cellular Immunology. 79: 36-43. PMID 6602661 DOI: 10.1016/0008-8749(83)90048-5  0.188
1989 Moore MA. Interactions between hematopoietic growth factors in normal and leukemic stem cell differentiation. Annals of the New York Academy of Sciences. 567: 171-81. PMID 2679317 DOI: 10.1111/j.1749-6632.1989.tb16469.x  0.187
1999 Möhle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. Regulation of transendothelial migration of hematopoietic progenitor cells. Annals of the New York Academy of Sciences. 872: 176-85; discussion 1. PMID 10372121 DOI: 10.1111/J.1749-6632.1999.Tb08463.X  0.186
1982 Moore MA. G-CSF: its relationship to leukemia differentiation-inducing activity and other hemopoietic regulators. Journal of Cellular Physiology. Supplement. 1: 53-64. PMID 6802860 DOI: 10.1002/JCP.1041130411  0.185
1987 Moore MA, Warren DJ. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proceedings of the National Academy of Sciences of the United States of America. 84: 7134-8. PMID 3499607 DOI: 10.1073/PNAS.84.20.7134  0.185
2002 Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MA, Nimer SD. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood. 99: 15-23. PMID 11756147 DOI: 10.1182/Blood.V99.1.15  0.185
2006 Moore MA, Shieh JH, Lee G. Hematopoietic cells. Methods in Enzymology. 418: 208-42. PMID 17141038 DOI: 10.1016/S0076-6879(06)18013-1  0.184
2014 Zhang Q, Johnston EV, Shieh JH, Moore MA, Danishefsky SJ. Synthesis of granulocyte-macrophage colony-stimulating factor as homogeneous glycoforms and early comparisons with yeast cell-derived material. Proceedings of the National Academy of Sciences of the United States of America. 111: 2885-90. PMID 24516138 DOI: 10.1073/Pnas.1400140111  0.184
2009 Weisel KC, Moore MA, Kanz L, Möhle R. Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support. Stem Cells and Development. 18: 229-34. PMID 18491948 DOI: 10.1089/scd.2008.0069  0.181
1995 Flasshove M, Banerjee D, Mineishi S, Li M, Bertino J, Moore M. Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer Blood. 85: 566-574. DOI: 10.1182/blood.V85.2.566.bloodjournal852566  0.181
2011 Hartwell KA, Miller PG, Stewart AL, Kahn AR, Logan DJ, Negri J, Duvet M, Chattopadhyay S, Shterental S, Chu LP, Shieh JH, Jaeraas M, Dancik V, Narayan R, Huang C, ... ... Moore MA, et al. Niche-Based Screening Reveals Leukemia Stem Cell Specific Therapeutics Blood. 118: 760-760. DOI: 10.1182/Blood.V118.21.760.760  0.178
1998 Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood. 92: 362-7. PMID 9657732 DOI: 10.1182/Blood.V92.2.362.414K38_362_367  0.178
2013 Khan S, Stewart AL, Mukherjee S, Scheiber SL, Ebert BL, Golub TR, Scadden DT, Moore MA. Ex Vivo expansion Of Umbilical Cord Blood CD34+ Cells Under Hypoxic Conditions Using Novel Compound#999 With Cytokines Blood. 122: 4508-4508. DOI: 10.1182/Blood.V122.21.4508.4508  0.178
1985 Platzer E, Welte K, Lu L, Gabrilove JL, Yung YP, Nathan CF, Mertelsmann R, Moore MA. Biological activities of a human pluripotent hemopoietic colony-stimulating factor Hamatologie Und Bluttransfusion. 29: 418-422. PMID 3875527 DOI: 10.1007/978-3-642-70385-0_85  0.178
1978 Kurland J, Broxmeyer H, Pelus L, Bockman R, Moore M. Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation Blood. 52: 388-407. DOI: 10.1182/blood.V52.2.388.bloodjournal522388  0.177
1978 Kurland J, Broxmeyer H, Pelus L, Bockman R, Moore M. Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation Blood. 52: 388-407. DOI: 10.1182/blood.v52.2.388.388  0.177
2006 He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massagué J. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell. 125: 929-41. PMID 16751102 DOI: 10.1016/J.Cell.2006.03.045  0.177
2001 Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 97: 3354-60. PMID 11369624 DOI: 10.1182/Blood.V97.11.3354  0.177
1998 Flasshove M, Banerjee D, Leonard JP, Mineishi S, Li MX, Bertino JR, Moore MA. Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA. Human Gene Therapy. 9: 63-71. PMID 9458243 DOI: 10.1089/Hum.1998.9.1-63  0.177
2012 Moore M. Andrew Stein: Longing for Nothingness: Resistance, Denial, and the Place of Death in the Nursing Home The American Journal of Psychoanalysis. 72: 86-89. DOI: 10.1057/Ajp.2011.51  0.176
1992 Moore MA. The use of colony stimulating factors in combination. Current Opinion in Biotechnology. 2: 854-62. PMID 1372191 DOI: 10.1016/S0958-1669(05)80121-1  0.176
2012 Kuriakose ET, Shieh J, Shieh JH, Silver RT, Moore MA. Monocytes Modulate Megakaryocyte-Mediated Fibrosis of Bone Marrow Stromal Cells in Vitro Blood. 120: 1759-1759. DOI: 10.1182/blood.v120.21.1759.1759  0.175
1987 Platzer E, Oez S, Welte K, Sendler A, Gabrilove JL, Mertelsmann R, Moore MA, Kalden JR. Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells. Immunobiology. 172: 185-93. PMID 3492429 DOI: 10.1016/S0171-2985(86)80098-5  0.175
1997 Möhle R, Green D, Moore MA, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proceedings of the National Academy of Sciences of the United States of America. 94: 663-8. PMID 9012841 DOI: 10.1073/Pnas.94.2.663  0.174
2013 Moore MA, Lim MK, Huang X. New APJCP impact factor for 2012 is 1.271--time to make a major effort to break through the 2.0 barrier. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 3377-8. PMID 23886116  0.173
2013 Moore MA, Lim MK, Huang XE. New APJCP impact factor for 2012 is 1.271 - time to make a major effort to break through the 2.0 barrier Asian Pacific Journal of Cancer Prevention. 14: 3377-3378. DOI: 10.7314/APJCP.2013.14.6.3377  0.173
2013 Tsai JJ, Dudakov JA, Takahashi K, Shieh JH, Velardi E, Holland AM, Singer NV, West ML, Smith OM, Young LF, Shono Y, Ghosh A, Hanash AM, Tran HT, Moore MA, et al. Nrf2 regulates haematopoietic stem cell function. Nature Cell Biology. 15: 309-16. PMID 23434824 DOI: 10.1038/Ncb2699  0.172
1975 Metcalf D, Moore MA. Growth and responsiveness of human granulocytic leukemic cells in vitro. Bibliotheca Haematologica. 235-41. PMID 1057945 DOI: 10.1159/000397538  0.171
2012 Chattopadhyay S, Stewart AL, Mukherjee S, Huang C, Hartwell KA, Miller PG, Carmody L, Yusuf RZ, Sykes DB, Vallet S, Santo L, Cirstea DD, Hideshima T, Dancik V, Cheah J, ... ... Moore MA, et al. Niche-Based Screening Identifies Novel Small Molecules That Overcome Stromal Effects in Multiple Myeloma Blood. 120: 571-571. DOI: 10.1182/Blood.V120.21.571.571  0.171
2001 Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Annals of the New York Academy of Sciences. 938: 36-45; discussion 45. PMID 11458524 DOI: 10.1111/J.1749-6632.2001.Tb03572.X  0.17
2014 Ady JW, Desir S, Thayanithy V, Vogel RI, Moreira AL, Downey RJ, Fong Y, Manova-Todorova K, Moore MA, Lou E. Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes. Frontiers in Physiology. 5: 400. PMID 25400582 DOI: 10.3389/fphys.2014.00400  0.17
1998 Rafii S, Mohle R, Shapiro F, Frey BM, Moore MA. Regulation of hematopoiesis by microvascular endothelium. Leukemia & Lymphoma. 27: 375-86. PMID 9477120 DOI: 10.3109/10428199709058305  0.17
2005 Feugier P, Li N, Jo DY, Shieh JH, MacKenzie KL, Lesesve JF, Latger-Cannard V, Bensoussan D, Crystal RG, Rafii S, Stoltz JF, Moore MA. Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro. Stem Cells and Development. 14: 505-16. PMID 16305336 DOI: 10.1089/Scd.2005.14.505  0.17
2012 Hoya-Arias R, Shen L, Mony U, Peguero E, Pera B, Moore MA. Temporal Generation and Molecular Characterization of Functional Hematopoietic Cells From Human Embryonic Stem Cells. Blood. 120: 2352-2352. DOI: 10.1182/blood.v120.21.2352.2352  0.17
2004 Perez LE, Alpdogan O, Shieh JH, Wong D, Merzouk A, Salari H, O'Reilly RJ, van den Brink MR, Moore MA. Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Experimental Hematology. 32: 300-7. PMID 15003316 DOI: 10.1016/J.Exphem.2003.12.005  0.17
2012 Shieh J, Su T, Shieh J, Moore MA. Derivation and Drug Screening of Growth Factors- and Stroma-Dependent Human Multiple Myeloma Cells Blood. 120: 5020-5020. DOI: 10.1182/BLOOD.V120.21.5020.5020  0.167
2004 Ye Q, Shieh JH, Morrone G, Moore MA. Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors. Leukemia. 18: 777-87. PMID 14961038 DOI: 10.1038/sj.leu.2403291  0.167
1990 Slørdal L, Muench MO, Warren DJ, Moore MA. Radioprotection by murine and human tumor-necrosis factor: dose-dependent effects on hematopoiesis in the mouse. European Journal of Haematology. 43: 428-34. PMID 2612616 DOI: 10.1111/j.1600-0609.1989.tb00331.x  0.167
2004 Weisel KC, Wu K, Kanz L, Moore MA. Long-Term Coculture of Adult Human Healthy Donor CD34+ Cells Shows Elevation of Telomeres in a Subgroup of Donors Independent of Age, Stem Cell Function and Telomerase Activity. Blood. 104: 1695-1695. DOI: 10.1182/blood.v104.11.1695.1695  0.166
2011 Kahn AR, Hartwell KA, Miller PG, Ebert BL, Golub TR, Moore MA. Selective Targeting of Leukemic Over Normal Stem Cells by the Serotonin Receptor Antagonist SB-216641 Blood. 118: 1884-1884. DOI: 10.1182/BLOOD.V118.21.1884.1884  0.165
1989 Gabrilove J, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore M, Clarkson B, Oettgen H, Alton K, Welte K, Souza L. Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium Journal of Urology. 141: 453-454. DOI: 10.1016/s0022-5347(17)40803-2  0.165
2004 Schuringa JJ, Chung KY, Morrone G, Moore MA. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation. The Journal of Experimental Medicine. 200: 623-35. PMID 15353555 DOI: 10.1084/jem.20041024  0.165
1976 Moore MA. Prediction of relapse and remission in AML by marrow culture criteria Nouvelle Revue Francaise D"Hematologie; Blood Cells. 17: 109-124. PMID 1069970 DOI: 10.1007/978-3-642-66312-3_7  0.165
1985 Ebell W, Castro-Malaspina H, Moore M, O'Reilly R. Depletion of stromal cell elements in human marrow grafts separated by soybean agglutinin Blood. 65: 1105-1111. DOI: 10.1182/blood.v65.5.1105.bloodjournal6551105  0.165
2004 Moldenhauer A, Frank RC, Pinilla-Ibarz J, Holland G, Boccuni P, Scheinberg DA, Salama A, Seeger K, Moore MA, Nimer SD. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins. Journal of Leukocyte Biology. 76: 623-33. PMID 15197237 DOI: 10.1189/Jlb.1103581  0.165
2013 Ambati SR, Lopes EC, Mony U, Kosugi K, Moreira A, Meyers P, Chiosis G, Moore M. Abstract 2752: Novel inhibitor of HSP90- PU-H71 exhibits significant activity in Ewing sarcoma pre-clinical models. Cancer Research. 73: 2752-2752. DOI: 10.1158/1538-7445.Am2013-2752  0.165
1985 Ebell W, Castro-Malaspina H, Moore M, O'Reilly R. Depletion of stromal cell elements in human marrow grafts separated by soybean agglutinin Blood. 65: 1105-1111. DOI: 10.1182/blood.v65.5.1105.1105  0.165
1990 Warren DJ, Slørdal L, Moore MA. Tumor-necrosis factor induces cell cycle arrest in multipotential hematopoietic stem cells: a possible radioprotective mechanism. European Journal of Haematology. 45: 158-63. PMID 2226728 DOI: 10.1111/j.1600-0609.1990.tb00444.x  0.164
1979 Mertelsmann R, Filippa DA, Koziner B, Grossbard E, Beck J, Moore MA, Lieberman PH, Clarkson BD, Gupta S, Good RA. Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomas. Advances in Experimental Medicine and Biology. 114: 553-60. PMID 313681 DOI: 10.1007/978-1-4615-9101-6_91  0.163
1983 Ralph P, Williams N, Moore MA, Litcofsky PB. Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester. Cellular Immunology. 71: 215-23. PMID 6754099 DOI: 10.1016/0008-8749(82)90257-X  0.163
1980 Castro-Malaspina H, Gay R, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer H, Moore M. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny Blood. 56: 289-301. DOI: 10.1182/Blood.V56.2.289.289  0.163
1991 Lemoli R, Gasparetto C, Scheinberg D, Moore M, Clarkson B, Gulati S. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination Blood. 77: 1829-1836. DOI: 10.1182/blood.v77.8.1829.1829  0.163
2005 Moore MA. Converging pathways in leukemogenesis and stem cell self-renewal. Experimental Hematology. 33: 719-37. PMID 15963848 DOI: 10.1016/J.EXPHEM.2005.04.011  0.162
2006 Weisel KC, Moore MA. Genetic and functional characterization of isolated stromal cell lines from the aorta-gonado-mesonephros region. Annals of the New York Academy of Sciences. 1044: 51-9. PMID 15958697 DOI: 10.1196/annals.1349.007  0.162
1995 Muench MO, Roncarolo MG, Namikawa R, Bárcena A, Moore MA. Progress in the ex vivo expansion of hematopoietic progenitors. Leukemia & Lymphoma. 16: 1-11. PMID 7696914 DOI: 10.3109/10428199409114134  0.162
2000 Jo DY, Rafii S, Hamada T, Moore MA. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. The Journal of Clinical Investigation. 105: 101-11. PMID 10619866 DOI: 10.1172/Jci7954  0.161
1985 Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MA. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proceedings of the National Academy of Sciences of the United States of America. 82: 1526-30. PMID 3871951 DOI: 10.1073/PNAS.82.5.1526  0.161
1996 Boogaerts MA, Brugger W, Carella AM, Cortés-Funes H, Fibbe WE, Hows J, Khayat D, Linch DC, Link H, Moore MA, Testa NG. Peripheral blood progenitor cell transplantation: where do we stand? Chairman's Summary of the European School of Oncology Task Force meeting Peripheral Blood progenitor cell's held September 29-30, 1995. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 1-4. PMID 8805940 DOI: 10.1093/ANNONC/7.SUPPL_2.1  0.161
2015 Zoellner H, Paknejad N, Manova K, Moore MA. A novel cell-stiffness-fingerprinting analysis by scanning atomic force microscopy: comparison of fibroblasts and diverse cancer cell lines. Histochemistry and Cell Biology. PMID 26357955 DOI: 10.1007/s00418-015-1363-x  0.16
1997 Moore MA. Stem cell proliferation: ex vivo and in vivo observations. Stem Cells (Dayton, Ohio). 239-48; discussion 2. PMID 9368348 DOI: 10.1002/STEM.5530150832  0.159
2004 Moore MA. Commentary: the role of cell migration in the ontogeny of the lymphoid system. Stem Cells and Development. 13: 1-21. PMID 15068689 DOI: 10.1089/154732804773099218  0.159
2005 Wu KD, Cho YS, Katz J, Ponomarev V, Chen-Kiang S, Danishefsky SJ, Moore MA. Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 102: 10640-5. PMID 16030145 DOI: 10.1073/Pnas.0504512102  0.158
1982 Castro-Malaspina H, Gay R, Jhanwar S, Hamilton J, Chiarieri D, Meyers P, Gay S, Moore M. Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders Blood. 59: 1046-1054. DOI: 10.1182/BLOOD.V59.5.1046.1046  0.158
1982 Castro-Malaspina H, Gay R, Jhanwar S, Hamilton J, Chiarieri D, Meyers P, Gay S, Moore M. Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders Blood. 59: 1046-1054. DOI: 10.1182/blood.v59.5.1046.bloodjournal5951046  0.158
1997 Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells Blood. 90: 182-193. DOI: 10.1182/blood.v90.1.182.182_182_193  0.158
1997 Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells Blood. 90: 182-193. DOI: 10.1182/blood.v90.1.182  0.158
1997 Möhle R, Moore MA, Nachman RL, Rafii S. Transendothelial Migration of CD34+ and Mature Hematopoietic Cells: An In Vitro Study Using a Human Bone Marrow Endothelial Cell Line Blood. 89: 72-80. DOI: 10.1182/Blood.V89.1.72.72_72_80  0.158
1994 Rafii S, Shapiro F, Rimarachin J, Nachman R, Ferris B, Weksler B, Moore M, Asch A. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion Blood. 84: 10-19. DOI: 10.1182/Blood.V84.1.10.10  0.158
2017 Codispoti B, Rinaldo N, Chiarella E, Lupia M, Spoleti CB, Marafioti MG, Aloisio A, Scicchitano S, Giordano M, Nappo G, Lucchino V, Moore MA, Zhou P, Mesuraca M, Bond HM, et al. Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells. Oncotarget. PMID 28187462 DOI: 10.18632/Oncotarget.15156  0.157
2012 Tajima K, Tsuda H, Moore MA. Requirement for asian pacific collaboration in assessment of nutritional factors impacting on cancer development Asian Pacific Journal of Cancer Prevention. 3: 93-96.  0.156
1980 Gulati SC, Mertelsmann R, Gee T, Good RA, Clarkson B, Moore MA, Koziner B. Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease. Cancer. 46: 725-9. PMID 6930987 DOI: 10.1002/1097-0142(19800815)46:4<725::Aid-Cncr2820460415>3.0.Co;2-6  0.156
2011 Amrani YM, Gill J, Matevossian A, Alonzo ES, Yang C, Shieh JH, Moore MA, Park CY, Sant'Angelo DB, Denzin LK. The Paf oncogene is essential for hematopoietic stem cell function and development. The Journal of Experimental Medicine. 208: 1757-65. PMID 21844206 DOI: 10.1084/Jem.20102170  0.155
2004 Moldenhauer A, Nociari M, Lam G, Salama A, Rafii S, Moore MA. Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells. Stem Cells (Dayton, Ohio). 22: 144-57. PMID 14990854 DOI: 10.1634/Stemcells.22-2-144  0.154
2009 Huang X, Liberto MD, Ely S, Jayabalan DS, Chen I, Wilner KD, Moore M, Niesvizky R, Chen-Kiang S. Induction of sequential G1 arrest and synchronous S phase entry by reversible CDK4/CDK6 inhibition sensitizes myeloma cells for cytotoxic killing through loss of IRF-4. Blood. 114: 299-299. DOI: 10.1182/blood.v114.22.299.299  0.154
2012 Lou E, Fujisawa S, Barlas A, Romin Y, Manova-Todorova K, Moore MA, Subramanian S. Tunneling Nanotubes: A new paradigm for studying intercellular communication and therapeutics in cancer. Communicative & Integrative Biology. 5: 399-403. PMID 23060969 DOI: 10.4161/cib.20569  0.154
1976 Moore MA. Clinical utility of bone marrow culture Hamatologie Und Bluttransfusion. 19: 79-90. PMID 795748 DOI: 10.1007/978-3-642-87524-3_8  0.153
2009 Dorn DC, Kou CA, Png KJ, Moore MA. The effect of cantharidins on leukemic stem cells. International Journal of Cancer. Journal International Du Cancer. 124: 2186-99. PMID 19123473 DOI: 10.1002/ijc.24157  0.153
2007 Weisel KC, Gao Y, Shieh JH, Moore MA. Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis. Experimental Hematology. 34: 1505-16. PMID 17046570 DOI: 10.1016/J.EXPHEM.2006.06.013  0.153
2015 Caldas Lopes E, Jae-Hung S, Ambati S, Tsann-Long S, Correa F, Peguero E, Moore MA. Novel Alkylating Agent, Ureidomustine Exhibit Pre-Clinical Efficacy in B-Cell Lymphoma with Minimal Dose-Limiting Myelotoxicity Blood. 126: 1556-1556. DOI: 10.1182/BLOOD.V126.23.1556.1556  0.152
1980 Moore M, Broxmeyer H, Sheridan A, Meyers P, Jacobsen N, Winchester R. Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells Blood. 55: 682-690. DOI: 10.1182/blood.V55.4.682.682  0.152
1987 Steinberg J, Moore MA, Bernhardt B, Bona CA, Platsoucas CD. Induction of proliferation and differentiation of leukaemic B cells from patients with chronic lymphocytic leukaemia by anti-mu and conditioned medium. Scandinavian Journal of Immunology. 25: 599-611. PMID 3110941 DOI: 10.1111/J.1365-3083.1987.Tb01086.X  0.152
2004 Gammaitoni L, Weisel KC, Gunetti M, Wu KD, Bruno S, Pinelli S, Bonati A, Aglietta M, Moore MA, Piacibello W. Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. Blood. 103: 4440-8. PMID 14726371 DOI: 10.1182/BLOOD-2003-09-3079  0.152
1979 Moore M, Sheridan A, Allen T, Dexter T. Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment Blood. 54: 775-793. DOI: 10.1182/BLOOD.V54.4.775.775  0.151
1978 Winchester RJ, Meyers PA, Broxmeyer HE, Wang CY, Moore MA, Kunkel HG. Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera. The Journal of Experimental Medicine. 148: 613-8. PMID 702050 DOI: 10.1084/jem.148.2.613  0.151
1998 Möhle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. The Chemokine Receptor CXCR-4 Is Expressed on CD34+Hematopoietic Progenitors and Leukemic Cells and Mediates Transendothelial Migration Induced by Stromal Cell-Derived Factor-1 Blood. 91: 4523-4530. DOI: 10.1182/Blood.V91.12.4523.412K04_4523_4530  0.15
1985 Siena S, Castro-Malaspina H, Gulati S, Lu L, Colvin M, Clarkson B, O'Reilly R, Moore M. Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow Blood. 65: 655-662. DOI: 10.1182/blood.v65.3.655.655  0.15
1981 Stuart R, Hamilton J, Sensenbrenner L, Moore M. Regulation of myelopoiesis in vitro: partial replacement of colony- stimulating factors by tumor-promoting phorbol esters Blood. 57: 1032-1042. DOI: 10.1182/blood.v57.6.1032.bloodjournal5761032  0.15
1981 Stuart R, Hamilton J, Sensenbrenner L, Moore M. Regulation of myelopoiesis in vitro: partial replacement of colony- stimulating factors by tumor-promoting phorbol esters Blood. 57: 1032-1042. DOI: 10.1182/BLOOD.V57.6.1032.1032  0.15
1981 Modak MJ, Mertelsmann R, Koziner B, Pahwa R, Moore MA, Clarkson BD, Good RA. A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias. Journal of Cancer Research and Clinical Oncology. 98: 91-104. PMID 6935216 DOI: 10.1007/Bf00413181  0.15
2010 Moore MA, Manan AA, Chow KY, Cornain SF, Devi CR, Triningsih FX, Laudico A, Mapua CA, Mirasol-Lumague MR, Noorwati S, Nyunt K, Othman NH, Shah SA, Sinuraya ES, Yip CH, et al. Cancer epidemiology and control in peninsular and island South-East Asia - past, present and future. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 81-98. PMID 20553070  0.15
2010 Eldjerou LK, Chaudhury S, Baisre-de Leon A, He M, Arcila ME, Heller G, O'Reilly RJ, Barker JN, Moore MA. An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood. 116: 3999-4006. PMID 20587781 DOI: 10.1182/Blood-2010-03-276212  0.148
1988 Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MA, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. The New England Journal of Medicine. 318: 1414-22. PMID 2452983 DOI: 10.1056/NEJM198806023182202  0.148
1998 Tajima Y, Huang EJ, Vosseller K, Ono M, Moore MA, Besmer P. Role of dimerization of the membrane-associated growth factor kit ligand in juxtacrine signaling: the Sl17H mutation affects dimerization and stability-phenotypes in hematopoiesis. The Journal of Experimental Medicine. 187: 1451-61. PMID 9565637 DOI: 10.1084/Jem.187.9.1451  0.148
2011 Shieh JH, Steinherz PG, Shieh J, Moore MA. In Vitro Culture Reveals Microenvironment-Dependent Growth, Heterogeneity and Hierarchical Structure of Primary Human Pediatric Pre-B Cell Acute Lymphoblastic Leukemia (pre-B ALL) Cells Blood. 118: 1483-1483. DOI: 10.1182/BLOOD.V118.21.1483.1483  0.148
2007 Lu SJ, Feng Q, Caballero S, Chen Y, Moore MA, Grant MB, Lanza R. Generation of functional hemangioblasts from human embryonic stem cells. Nature Methods. 4: 501-9. PMID 17486087 DOI: 10.1038/Nmeth1041  0.148
1985 Feldman RA, Gabrilove JL, Tam JP, Moore MA, Hanafusa H. Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells Proceedings of the National Academy of Sciences of the United States of America. 82: 2379-2383. PMID 2986115 DOI: 10.1073/Pnas.82.8.2379  0.148
1980 Broxmeyer HE, Ralph P, Margolis VB, Nakoinz I, Meyers P, Kapoor N, Moore MA. Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA). Leukemia Research. 3: 193-203. PMID 533990 DOI: 10.1016/0145-2126(79)90042-0  0.147
1973 Moore MA, Williams N, Metcalf D. In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells. Journal of the National Cancer Institute. 50: 603-23. PMID 4513522 DOI: 10.1093/JNCI/50.3.603  0.147
2010 Morozov A, Downey RJ, Healey J, Moreira AL, Lou E, Franceschino A, Dogan Y, Leung R, Edgar M, LaQuaglia M, Maki RG, Moore MA. Benign mesenchymal stromal cells in human sarcomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5630-40. PMID 21138865 DOI: 10.1158/1078-0432.Ccr-09-2886  0.147
2006 Chung KY, Morrone G, Schuringa JJ, Plasilova M, Shieh JH, Zhang Y, Zhou P, Moore MA. Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation. Cancer Research. 66: 11781-91. PMID 17178874 DOI: 10.1158/0008-5472.Can-06-0706  0.146
2010 Promthet SS, Pientong C, Ekalaksananan T, Wiangnon S, Poomphakwaen K, Songserm N, Chopjitt P, Moore MA, Tokudome S. Risk factors for colon cancer in Northeastern Thailand: interaction of MTHFR codon 677 and 1298 genotypes with environmental factors. Journal of Epidemiology / Japan Epidemiological Association. 20: 329-38. PMID 20551579 DOI: JST.JSTAGE/jea/JE20090140  0.146
2000 Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Witte L, Moore MA, Rafii S. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. The Journal of Clinical Investigation. 106: 511-21. PMID 10953026 DOI: 10.1172/Jci8978  0.146
1978 Kurland JI, Traganos F, Darzynkiewicz Z, Moore MA. Macrophage-mediated cytostasis of neoplastic hemopoietic cells: cytofluorometric analysis of the reversible cell cycle block. Cellular Immunology. 36: 318-30. PMID 630611 DOI: 10.1016/0008-8749(78)90276-9  0.146
2013 Pera B, Jordi M, Hoya-Arias R, Díaz JF, Fang W, Altmann K, Moore MA. Anti-Neoplastic Effect Of High Affinity and Covalent-Binding Microtubule Stabilizing Agents In AML Cells Sensitive and Resistant By ABC-Transporter Overexpression Blood. 122: 4225-4225. DOI: 10.1182/BLOOD.V122.21.4225.4225  0.146
2005 Chen-Kiang S, Ely S, Di Liberto M, Wu K, Shaughnessy J, Moore M, Niesvizky R, Hatada E. Aberrant Autocrine and Paracrine CD40L Signaling Promotes Primary Myeloma Cell Survival and Attenuates Bortezomib-Induced Apoptosis. Blood. 106: 1564-1564. DOI: 10.1182/BLOOD.V106.11.1564.1564  0.146
2012 Tsuda H, Moore MA. Cancer screening: A review with particular attention to areas for future international research efforts Asian Pacific Journal of Cancer Prevention. 3: 99-123.  0.146
2010 Moore MA, Sobue T. Strategies for cancer control on an organ-site basis. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 149-64. PMID 20553073  0.146
1973 Moore MA, Williams N, Metcalf D. In vitro colony formation by normal and leukemic human hematopoietic cells: interaction between colony-forming and colony-stimulating cells. Journal of the National Cancer Institute. 50: 591-602. PMID 4513521 DOI: 10.1093/JNCI/50.3.591  0.145
1976 Kagan WA, Ascensão JA, Pahwa RN, Hansen JA, Goldstein G, Valera EB, Incefy GS, Moore MA, Good RA. Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis. Proceedings of the National Academy of Sciences of the United States of America. 73: 2890-4. PMID 1085449 DOI: 10.1073/Pnas.73.8.2890  0.145
2005 Lee G, Sheih J, Hwang W, Moore MA. Step-Wise Differentiation of CD34+ Cell Derived from Nuclear Transfer-Human Embryonic Stem Cells into Myeloid and Lymphoid Precursors. Blood. 106: 3614-3614. DOI: 10.1182/Blood.V106.11.3614.3614  0.145
1999 Albanell J, Bosl GJ, Reuter VE, Engelhardt M, Franco S, Moore MA, Dmitrovsky E. Telomerase activity in germ cell cancers and mature teratomas. Journal of the National Cancer Institute. 91: 1321-6. PMID 10433622 DOI: 10.1093/Jnci/91.15.1321  0.145
2012 Shieh J, Su T, Shieh J, Moore MA. Drug Screening of Primary Human Pediatric Pre-B Cell Acute Lymphoblastic Leukemia (pre-B ALL) Cells in Their Stromal Niche Blood. 120: 4295-4295. DOI: 10.1182/BLOOD.V120.21.4295.4295  0.145
1994 Moore MA. Ex vivo expansion and gene therapy using cord blood CD34+ cells. Journal of Hematotherapy. 2: 221-4. PMID 7522878 DOI: 10.1089/SCD.1.1993.2.221  0.144
1997 Deshpande RV, Peterson RH, Moore MA. Protein tyrosine kinases in granulocyte colony stimulating factor receptor signal transduction, myeloid cell proliferation, and neutrophil activation. Life Sciences. 60: 587-604. PMID 9048962 DOI: 10.1016/S0024-3205(96)00697-2  0.144
2010 Weisel KC, Kopp HG, Moore MA, Studer L, Barberi T. Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells. Stem Cells and Development. 19: 745-51. PMID 19422288 DOI: 10.1089/Scd.2008.0356  0.144
1982 Dunn CD, Jones JB, Lange RD, Wright EG, Moore MA. Production of presumptive humoral haematopoietic regulators in canine cyclic haematopoiesis. Cell and Tissue Kinetics. 15: 1-10. PMID 7060078 DOI: 10.1111/j.1365-2184.1982.tb01018.x  0.143
2003 Mulloy JC, Cammenga J, Berguido FJ, Wu K, Zhou P, Comenzo RL, Jhanwar S, Moore MA, Nimer SD. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood. 102: 4369-76. PMID 12946995 DOI: 10.1182/Blood-2003-05-1762  0.142
2014 Caldas Lopes E, Correa F, Peguero E, Ambati SR, Shieh JH, SU TL, Moore MA. Pre-Clinical Evaluation of a Novel DNA Crosslinking Agent, Bo-1055 in B-Cell Lymphoma Blood. 124: 5483-5483. DOI: 10.1182/BLOOD.V124.21.5483.5483  0.142
1985 Wang S, Castro-Malaspina H, Lu L, Moore M. Biological characterization of a granulomonopoietic enhancing activity derived from cultured human lipid-containing macrophages Blood. 65: 1181-1190. DOI: 10.1182/BLOOD.V65.5.1181.1181  0.141
2004 Nimer SD, Moore MA. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells. Oncogene. 23: 4249-54. PMID 15156180 DOI: 10.1038/sj.onc.1207673  0.14
2014 Ullah M, Cox S, Kelly E, Moore MA, Zoellner H. Arecoline increases basic fibroblast growth factor but reduces expression of IL-1, IL-6, G-CSF and GM-CSF in human umbilical vein endothelium. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. PMID 25529330 DOI: 10.1111/jop.12276  0.14
2010 Deshpande S, Agosti V, Manova K, Moore MA, Hardy MP, Besmer P. Kit ligand cytoplasmic domain is essential for basolateral sorting in vivo and has roles in spermatogenesis and hematopoiesis. Developmental Biology. 337: 199-210. PMID 19874813 DOI: 10.1016/J.Ydbio.2009.10.022  0.139
2002 MacKenzie KL, Franco S, Naiyer AJ, May C, Sadelain M, Rafii S, Moore MA. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene. 21: 4200-11. PMID 12082607 DOI: 10.1038/Sj.Onc.1205425  0.139
2013 Hartwell KA, Miller PG, Mukherjee S, Kahn AR, Stewart AL, Logan DJ, Negri JM, Duvet M, Järås M, Puram R, Dancik V, Al-Shahrour F, Kindler T, Tothova Z, Chattopadhyay S, ... ... Moore MA, et al. Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. Nature Chemical Biology. 9: 840-8. PMID 24161946 DOI: 10.1038/Nchembio.1367  0.139
2007 Kim K, Ng K, Rugg-Gunn PJ, Shieh JH, Kirak O, Jaenisch R, Wakayama T, Moore MA, Pedersen RA, Daley GQ. Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell. 1: 346-52. PMID 18371368 DOI: 10.1016/J.Stem.2007.07.001  0.138
2004 Ghannam G, Takeda A, Camarata T, Moore MA, Viale A, Yaseen NR. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells. The Journal of Biological Chemistry. 279: 866-75. PMID 14561764 DOI: 10.1074/Jbc.M307280200  0.138
2012 Wang P, Dong S, Brailsford JA, Iyer K, Townsend SD, Zhang Q, Hendrickson RC, Shieh J, Moore MA, Danishefsky SJ. At last: erythropoietin as a single glycoform. Angewandte Chemie (International Ed. in English). 51: 11576-84. PMID 23012228 DOI: 10.1002/Anie.201206090  0.138
2015 Kyoizumi S, Kubo Y, Misumi M, Kajimura J, Yoshida K, Hayashi T, Imai K, Ohishi W, Nakachi K, Young LF, Shieh JH, Moore MA, van den Brink MR, Kusunoki Y. Circulating Hematopoietic Stem and Progenitor Cells in Aging Atomic Bomb Survivors. Radiation Research. PMID 26720799 DOI: 10.1667/RR14209.1  0.137
2014 Xie Y, Hicks MJ, Kaminsky SM, Moore MA, Crystal RG, Rafii A. AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer. Gynecologic Oncology. 135: 325-32. PMID 25108232 DOI: 10.1016/J.Ygyno.2014.07.105  0.137
2011 Funasaka T, Nakano H, Wu Y, Hashizume C, Gu L, Nakamura T, Wang W, Zhou P, Moore MA, Sato H, Wong RW. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis. Cell Cycle (Georgetown, Tex.). 10: 1456-67. PMID 21467841 DOI: 10.4161/Cc.10.9.15494  0.137
1983 Venuta S, Mertelsmann R, Welte K, Feldman S, Wang C, Moore M. Production and regulation of interleukin-2 in human lymphoblastic leukemias studied with T-cell monoclonal antibodies Blood. 61: 781-789. DOI: 10.1182/BLOOD.V61.4.781.781  0.137
1983 Venuta S, Mertelsmann R, Welte K, Feldman S, Wang C, Moore M. Production and regulation of interleukin-2 in human lymphoblastic leukemias studied with T-cell monoclonal antibodies Blood. 61: 781-789. DOI: 10.1182/blood.v61.4.781.bloodjournal614781  0.137
2005 Plasilova M, Chung K, Shieh JH, Fields RJ, Morrone G, Chadburn A, Knowles DM, Zhou P, Moore MA. Depletion of NUP98: A Common Leukemogenetic Mechanism in AML? Blood. 106: 667-667. DOI: 10.1182/Blood.V106.11.667.667  0.136
2009 Shieh JH, Silver RT, Adriano F, Moore M. A Novel in Vitro Model of Focal Fibrosis in Bone Marrow Stromal Co-Culture of CD34+ Cells From Patients with Idiopathic Myelofibrosis. Blood. 114: 2896-2896. DOI: 10.1182/BLOOD.V114.22.2896.2896  0.135
2006 Wierenga AT, Schepers H, Moore MA, Vellenga E, Schuringa JJ. STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha. Blood. 107: 4326-33. PMID 16455947 DOI: 10.1182/BLOOD-2005-11-4608  0.135
2021 Elgafy H, Wetzell B, Gillette M, Semaan H, Rowland A, Balboa CA, Mierzwa TA, McLean JB, Dorsch K, Moore MA. Lumbar spine fusion outcomes using a cellular bone allograft with lineage-committed bone-forming cells in 96 patients. Bmc Musculoskeletal Disorders. 22: 699. PMID 34404368 DOI: 10.1186/s12891-021-04584-z  0.135
1983 Punjabi CJ, Moore MA, Ralph P. Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells. Cellular Immunology. 77: 13-22. PMID 6839366 DOI: 10.1016/0008-8749(83)90002-3  0.134
1982 Welte K, Wang CY, Mertelsmann R, Venuta S, Feldman SP, Moore MA. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity. The Journal of Experimental Medicine. 156: 454-64. PMID 6980256 DOI: 10.1084/JEM.156.2.454  0.134
2012 Lou E, Fujisawa S, Morozov A, Barlas A, Romin Y, Dogan Y, Gholami S, Moreira AL, Manova-Todorova K, Moore MA. Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma. Plos One. 7: e33093. PMID 22427958 DOI: 10.1371/journal.pone.0033093  0.134
2006 Chaudhury S, Zakarzewski J, Shieh J, van der Brink M, Moore MA. Generation of Human T/NK Cell Precursors for Adoptive Transfer To Enhance Immune Reconstitution in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Blood. 108: 3209-3209. DOI: 10.1182/BLOOD.V108.11.3209.3209  0.133
1978 Williams N, Jackson H, Sheridan A, Murphy MJ, Elste A, Moore M. Regulation of megakaryopoiesis in long-term murine bone marrow cultures Blood. 51: 245-255. DOI: 10.1182/BLOOD.V51.2.245.245  0.133
1985 Lu L, Broxmeyer H, Moore M, Sheridan A, Gentile P. Abnormalities in myelopoietic regulatory interactions with acidic isoferritins and lactoferrin in mice infected with Friend virus complex: association with altered expression of Ia antigens on effector and responding cells Blood. 65: 91-99. DOI: 10.1182/BLOOD.V65.1.91.91  0.133
2013 Moore MA. Update on the APJCP and the APOCP in 2013 - what is going to be achieved in the future? Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 2151-3. PMID 23725104 DOI: 10.7314/APJCP.2013.14.4.2151  0.133
1985 Lu L, Broxmeyer H, Moore M, Sheridan A, Gentile P. Abnormalities in myelopoietic regulatory interactions with acidic isoferritins and lactoferrin in mice infected with Friend virus complex: association with altered expression of Ia antigens on effector and responding cells Blood. 65: 91-99. DOI: 10.1182/blood.v65.1.91.bloodjournal65191  0.133
2007 Skokowa J, Gupta K, Brechlin AM, Meyer J, Moore MA, Welte K. Constitutive Activation of STAT5a in Myeloid Progenitors of Severe Congenital Neutropenia Patients Leads to Downregulation of LEF-1. Blood. 110: 663-663. DOI: 10.1182/BLOOD.V110.11.663.663  0.132
1977 Shah R, Caporale L, Moore M. Characterization of colony-stimulating activity produced by human monocytes and phytohemagglutinin-stimulated lymphocytes Blood. 50: 811-821. DOI: 10.1182/BLOOD.V50.5.811.BLOODJOURNAL505811  0.131
1982 Pelus L, Saletan S, Silver R, Moore M. Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E Blood. 59: 284-292. DOI: 10.1182/BLOOD.V59.2.284.284  0.131
1982 Pelus L, Saletan S, Silver R, Moore M. Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E Blood. 59: 284-292. DOI: 10.1182/blood.v59.2.284.bloodjournal592284  0.131
2005 Ertem SA, Wu K, Ponomarev V, Chin AC, Moore MA. The Telomerase Template Antagonist GRN163L in Combination with Chemotherapeutics Reduces Tumor Volume in Multiple Myeloma Xenograft Models. Blood. 106: 3477-3477. DOI: 10.1182/Blood.V106.11.3477.3477  0.131
2003 Wang ES, O'Connor O, She Y, Zelenetz AD, Sirotnak FM, Moore MA. Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression. Leukemia & Lymphoma. 44: 1027-35. PMID 12854905 DOI: 10.1080/1042819031000077124  0.131
2008 Leung RC, Dorn DC, Downey RJ, Levine DA, Moore MA. Identification and Characterization of Hematopoietic Stem (HSC)/Progenitor Cells in Human Solid Tumors Blood. 112: 4785-4785. DOI: 10.1182/blood.v112.11.4785.4785  0.13
1991 Smith C, Gasparetto C, Collins N, Gillio A, Muench M, O'Reilly R, Moore M. Purification and partial characterization of a human hematopoietic precursor population Blood. 77: 2122-2128. DOI: 10.1182/BLOOD.V77.10.2122.2122  0.13
1991 Smith C, Gasparetto C, Collins N, Gillio A, Muench M, O'Reilly R, Moore M. Purification and partial characterization of a human hematopoietic precursor population Blood. 77: 2122-2128. DOI: 10.1182/blood.v77.10.2122.bloodjournal77102122  0.13
2003 Moldenhauer A, Nociari MM, Dias S, Lalezari P, Moore MA. Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes. Vox Sanguinis. 84: 228-36. PMID 12670372 DOI: 10.1046/J.1423-0410.2003.00283.X  0.13
1978 Mertelsmann R, Koziner B, Ralph R, Filippa D, McKenzie S, Arlin Z, Gee T, Moore M, Clarkson B. Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia Blood. 51: 1051-1056. DOI: 10.1182/blood.v51.6.1051.1051  0.129
1999 Naiyer AJ, Jo D, Ahn J, Mohle R, Peichev M, Lam G, Silverstein RL, Moore MA, Rafii S. Stromal Derived Factor-1–Induced Chemokinesis of Cord Blood CD34+ Cells (Long-Term Culture-Initiating Cells) Through Endothelial Cells Is Mediated by E-Selectin Blood. 94: 4011-4019. DOI: 10.1182/blood.v94.12.4011.424k10_4011_4019  0.129
1978 Mertelsmann R, Koziner B, Ralph R, Filippa D, McKenzie S, Arlin Z, Gee T, Moore M, Clarkson B. Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia Blood. 51: 1051-1056. DOI: 10.1182/blood.v51.6.1051.bloodjournal5161051  0.129
1974 Moore MA, Ekert H, Fitzgerald MG, Carmichael A. Evidence for the Clonal Origin of Chronic Myeloid Leukemia From a Sex Chromosome Mosaic: Clinical, Cytogenetic, and Marrow Culture Studies Blood. 43: 15-22. DOI: 10.1182/BLOOD.V43.1.15.15  0.129
2016 Saiyachak K, Tongsotsang S, Saenrueang T, Moore MA, Promthet S. Prevalence and factors associated with Opisthorchis viverrini infection in Khammouane Province, Lao PDR Asian Pacific Journal of Cancer Prevention. 17: 1589-1593. DOI: 10.7314/APJCP.2016.17.3.1589  0.129
2013 Lee J, Shieh JH, Zhang J, Liu L, Zhang Y, Eom JY, Morrone G, Moore MA, Zhou P. Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL4-mediated degradation of HOXB4. Blood. 121: 4082-9. PMID 23520338 DOI: 10.1182/Blood-2012-09-455204  0.128
2010 Dufault M, Duquette CE, Ehmann J, Hehl R, Lavin M, Martin V, Moore MA, Sargent S, Stout P, Willey C. Translating an evidence-based protocol for nurse-to-nurse shift handoffs. Worldviews On Evidence-Based Nursing / Sigma Theta Tau International, Honor Society of Nursing. 7: 59-75. PMID 20345512 DOI: 10.1111/J.1741-6787.2010.00189.X  0.128
2012 Kutter BL, Hutchinson TC, Moore MA, Kunnath S, Deng L. Influence of physical modeling on adoption of rocking foundations in practice Geotechnical Special Publication. 2017-2026. DOI: 10.1061/9780784412121.207  0.128
2012 Sagae S, Mori M, Moore MA. Risk factors for ovarian cancers: Do subtypes require separate treatment in epidemiological studies? Asian Pacific Journal of Cancer Prevention. 3: 5-16.  0.128
2006 Moldenhauer A, Moore MA, Schmidt K, Kiesewetter H, Salama A. Differences in the transmigration of different dendritic cells. Experimental Hematology. 34: 745-52. PMID 16728279 DOI: 10.1016/j.exphem.2006.02.010  0.127
2015 Chattopadhyay S, Stewart AL, Mukherjee S, Huang C, Hartwell KA, Miller PG, Subramanian R, Carmody LC, Yusuf RZ, Sykes DB, Paulk J, Vetere A, Vallet S, Santo L, Cirstea DD, ... ... Moore MA, et al. Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. Cell Reports. PMID 25660025 DOI: 10.1016/J.Celrep.2015.01.017  0.127
1988 Steinberg J, Bona C, Polyzos A, Moore MA, Platsoucas CD. Proliferation of leukemic B cells in response to SAC and anti-mu. Evidence for different modes of action and comparison to proliferation and differentiation induced by conditioned medium. Leukemia Research. 12: 559-66. PMID 3262791 DOI: 10.1016/0145-2126(88)90085-9  0.127
2012 Lopes EC, Correa FM, Shen L, Shieh J, Taldone T, Chiosis G, Moore MA. Anti-Apoptotic Bcl2 and Bcl-Xl Proteins Involved in Stroma-Induced Drug Tolerance to Hsp70 and Hsp90 Inhibitors in Leukemia and B-Cell Lymphoma Blood. 120: 4900-4900. DOI: 10.1182/Blood.V120.21.4900.4900  0.126
1993 Gillio A, Faulkner L, Alter B, Reilly L, Klafter R, Heller G, Young D, Lipton J, Moore M, O'Reilly R. Treatment of Diamond-Blackfan anemia with recombinant human interleukin- 3 [see comments] Blood. 82: 744-751. DOI: 10.1182/Blood.V82.3.744.Bloodjournal823744  0.126
1979 Kincade PW, Lee G, Fernandes G, Moore MA, Williams N, Good RA. Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice Proceedings of the National Academy of Sciences of the United States of America. 76: 3464-3468. PMID 115001 DOI: 10.1073/Pnas.76.7.3464  0.126
2001 Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlen P, Moore MA, Rafii S. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proceedings of the National Academy of Sciences of the United States of America. 98: 10857-62. PMID 11553814 DOI: 10.1073/Pnas.191117498  0.126
2014 Chiarella E, Carrà G, Scicchitano S, Codispoti B, Mega T, Lupia M, Pelaggi D, Marafioti MG, Aloisio A, Giordano M, Nappo G, Spoleti CB, Grillone T, Giovannone ED, Spina R, ... ... Moore MA, et al. UMG Lenti: novel lentiviral vectors for efficient transgene- and reporter gene expression in human early hematopoietic progenitors. Plos One. 9: e114795. PMID 25502183 DOI: 10.1371/journal.pone.0114795  0.126
1988 Lothrop CJ, Warren D, Souza L, Jones J, Moore M. Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor Blood. 72: 1324-1328. DOI: 10.1182/BLOOD.V72.4.1324.1324  0.125
1977 Horland AA, Wolman SR, Murphy MJ, Moore MA. Proliferation of erythroid colonies in semi-solid agar. British Journal of Haematology. 36: 495-9. PMID 889716 DOI: 10.1111/j.1365-2141.1977.tb00989.x  0.125
2002 Feugier P, Jo DY, Shieh JH, MacKenzie KL, Rafii S, Crystal RG, Moore MA. Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand. Journal of Hematotherapy & Stem Cell Research. 11: 127-38. PMID 11847009 DOI: 10.1089/152581602753448595  0.125
2010 Miyata Y, Liu Y, Jankovic V, Sashida G, Lee JM, Shieh JH, Naoe T, Moore M, Nimer SD. Cyclin C regulates human hematopoietic stem/progenitor cell quiescence. Stem Cells (Dayton, Ohio). 28: 308-17. PMID 19967789 DOI: 10.1002/Stem.270  0.125
1993 Gillio AP, Faulkner LB, Alter BP, Reilly L, Klafter R, Heller G, Young DC, Lipton JM, Moore MA, O'Reilly RJ. Successful treatment of Diamond-Blackfan anemia with interleukin 3. Stem Cells (Dayton, Ohio). 123-30. PMID 7691318 DOI: 10.1002/Stem.5530110820  0.125
2016 Ambati SR, Shieh JH, Pera B, Lopes EC, Chaudhry A, Wong EW, Saxena A, Su TL, Moore MA. BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models. Oncotarget. PMID 27248664 DOI: 10.18632/oncotarget.9657  0.124
1997 Reichman TW, Albanell J, Wang X, Moore MA, Studzinski GP. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. Journal of Cellular Biochemistry. 67: 13-23. PMID 9328835 DOI: 10.1002/(SICI)1097-4644(19971001)67:1<13::AID-JCB2>3.0.CO;2-Z  0.124
1971 Warner NL, Moore MA. Defects in hematopoietic differentiation in NZB and NZC mice. The Journal of Experimental Medicine. 134: 313-34. PMID 4934499 DOI: 10.1084/JEM.134.2.313  0.124
2015 Roberts AG, Johnston EV, Shieh JH, Sondey JP, Hendrickson RC, Moore MA, Danishefsky SJ. Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected Peptides. Journal of the American Chemical Society. 137: 13167-75. PMID 26401918 DOI: 10.1021/Jacs.5B08754  0.124
1980 Jacobsen N, Broxmeyer HE, Winchester RJ, Moore MA. Expression of DR antigens on early human progenitors of neutrophilic and eosinophilic colonies in diffusion chambers (CFUd). Scandinavian Journal of Haematology. 24: 227-33. PMID 6154965 DOI: 10.1111/j.1600-0609.1980.tb01330.x  0.124
2008 Eldjerou LK, Chaudhury S, He M, Arcila ME, Salazar PA, O’Reilly RJ, Barker JN, Moore MA. Graft-Vs-Graft Immune Interaction Is the Likely Mechanism of Absolute Unit Dominance in Double Unit Cord Blood (DCB) Transplantation Using Patient DCB Grafts: An in Vivo but Not in Vitro Phenomenon Blood. 112: 3486-3486. DOI: 10.1182/BLOOD.V112.11.3486.3486  0.124
2014 Ambati SR, Lopes EC, Kosugi K, Mony U, Zehir A, Shah SK, Taldone T, Moreira AL, Meyers PA, Chiosis G, Moore MA. Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma. Molecular Oncology. 8: 323-36. PMID 24388362 DOI: 10.1016/J.Molonc.2013.12.005  0.124
2001 Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. The Journal of Experimental Medicine. 193: 1005-14. PMID 11342585 DOI: 10.1084/Jem.193.9.1005  0.123
2008 Chen-Kiang S, Di Liberto M, Louie T, Liang J, Jayabalan DS, Ely S, Moore MA, Niesvizky R, Huang X. Targeting Cdk4/6 in combination therapy of chemoresistant multiple myeloma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 8503. PMID 27950981 DOI: 10.1200/jco.2008.26.15_suppl.8503  0.123
2004 Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ, Moore MA. Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. Blood. 104: 2893-902. PMID 15238424 DOI: 10.1182/BLOOD-2004-01-0226  0.123
2014 Thayanithy V, Babatunde V, Dickson EL, Wong P, Oh S, Ke X, Barlas A, Fujisawa S, Romin Y, Moreira AL, Downey RJ, Steer CJ, Subramanian S, Manova-Todorova K, Moore MA, et al. Tumor exosomes induce tunneling nanotubes in lipid raft-enriched regions of human mesothelioma cells. Experimental Cell Research. 323: 178-88. PMID 24468420 DOI: 10.1016/j.yexcr.2014.01.014  0.123
2017 Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, Moore MA, van den Brink MRM, Kusunoki Y. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. Journal of Immunology (Baltimore, Md. : 1950). PMID 28893953 DOI: 10.4049/jimmunol.1601711  0.123
1993 Muench MO, Gasparetto C, Moore MA. The in vitro growth of murine high proliferative potential-colony forming cells is not enhanced by growth in a low oxygen atmosphere. Cytokine. 4: 488-94. PMID 1292631 DOI: 10.1016/1043-4666(92)90009-G  0.123
2007 Moore MA, Dorn DC, Schuringa JJ, Chung KY, Morrone G. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Experimental Hematology. 35: 105-16. PMID 17379095 DOI: 10.1016/J.EXPHEM.2007.01.018  0.123
1978 Williams N, Eger RR, Moore MA, Mendelsohn N. Differentiation of mouse bone marrow precursor cells into neutrophil granulocytes by an activity separation from WEHI-3 cell-conditioned medium. Differentiation; Research in Biological Diversity. 11: 59-63. PMID 308018 DOI: 10.1111/J.1432-0436.1978.TB00970.X  0.122
1981 Tertian G, Yung YP, Moore MA. Induction and long-term maintenance of Thy-1 positive T lymphocytes: derivation from continuous bone marrow cultures. Journal of Supramolecular Structure. 13: 533-9. PMID 6112289 DOI: 10.1002/JSS.400130412  0.122
2013 Walters MS, Gomi K, Ashbridge B, Moore MA, Arbelaez V, Heldrich J, Ding BS, Rafii S, Staudt MR, Crystal RG. Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity. Respiratory Research. 14: 135. PMID 24298994 DOI: 10.1186/1465-9921-14-135  0.122
2010 Moore MA, Yoo KY, Tuncer M, Sobue T. Overview of players and information in the cancer epidemiology and control world in Asia. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 1-10. PMID 20553064  0.121
2014 Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, Young LF, Moore MA, van den Brink MR, Kusunoki Y. Linkage between dendritic and T cell commitments in human circulating hematopoietic progenitors. Journal of Immunology (Baltimore, Md. : 1950). 192: 5749-60. PMID 24835400 DOI: 10.4049/jimmunol.1303260  0.121
2012 Moore MA. APOCP/APJCP questionnaire points for discussion at the first APOCP general conference - is an asian pacificorganization for cancer control warranted? Asian Pacific Journal of Cancer Prevention. 3: 181-182.  0.121
1994 Shapiro F, Yao T, Raptis G, Reich L, Norton L, Moore M. Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer Blood. 84: 3567-3574. DOI: 10.1182/blood.v84.10.3567.3567  0.121
1994 Shapiro F, Yao T, Raptis G, Reich L, Norton L, Moore M. Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer Blood. 84: 3567-3574. DOI: 10.1182/blood.V84.10.3567.bloodjournal84103567  0.121
1993 Muench M, Firpo M, Moore M. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential Blood. 81: 3463-3473. DOI: 10.1182/BLOOD.V81.12.3463.3463  0.12
2013 Deshpande S, Bosbach B, Yozgat Y, Park CY, Moore MA, Besmer P. KIT receptor gain-of-function in hematopoiesis enhances stem cell self-renewal and promotes progenitor cell expansion. Stem Cells (Dayton, Ohio). 31: 1683-95. PMID 23681919 DOI: 10.1002/Stem.1419  0.12
1993 Muench M, Firpo M, Moore M. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential Blood. 81: 3463-3473. DOI: 10.1182/blood.v81.12.3463.bloodjournal81123463  0.12
1999 Worgall S, Singh R, Leopold PL, Kaner RJ, Hackett NR, Topf N, Moore MA, Crystal RG. Selective Expansion of Alveolar Macrophages In Vivo by Adenovirus-Mediated Transfer of the Murine Granulocyte-Macrophage Colony-Stimulating Factor cDNA Blood. 93: 655-666. DOI: 10.1182/Blood.V93.2.655.402K02_655_666  0.12
2003 Franco S, Ozkaynak MF, Sandoval C, Tugal O, Jayabose S, Engelhardt M, Moore MA. Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. Leukemia. 17: 401-10. PMID 12592340 DOI: 10.1038/sj.leu.2402815  0.12
2004 Chung KY, Morrone G, Schuringa JJ, Wong B, Dorn DC, Moore MA. Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis. Blood. 105: 77-84. PMID 15242879 DOI: 10.1182/BLOOD-2003-12-4445  0.119
2001 Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, ... Moore MA, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine. 7: 1194-201. PMID 11689883 DOI: 10.1038/Nm1101-1194  0.119
1999 Moore MA. "Turning brain into blood"--clinical applications of stem-cell research in neurobiology and hematology. The New England Journal of Medicine. 341: 605-7. PMID 10451469 DOI: 10.1056/NEJM199908193410811  0.119
1981 Straus DJ, Mertelsmann R, Koziner B, McKenzie S, de Harven E, Arlin ZA, Kempin S, Broxmeyer H, Moore MA, Menendez-Botet CJ, Gee TS, Clarkson BD. The acute monocytic leukemias: multidisciplinary studies in 45 patients. Medicine. 59: 409-25. PMID 7003298 DOI: 10.1097/00005792-198011000-00002  0.119
1991 Moore M. Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators Blood. 78: 1-19. DOI: 10.1182/BLOOD.V78.1.1.1  0.119
1980 Wright EG, Sheridan P, Moore MA. An inhibitor of murine stem cell proliferation produced by normal human bone marrow. Leukemia Research. 4: 309-14. PMID 7412364 DOI: 10.1016/0145-2126(80)90038-7  0.119
2004 Budak-Alpdogan T, Alpdogan O, Banerjee D, Wang E, Moore MA, Bertino JR. Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 574-84. PMID 15336657 DOI: 10.1016/J.Ymthe.2004.06.115  0.118
2010 Oskarsson T, Nagorny P, Krauss IJ, Perez L, Mandal M, Yang G, Ouerfelli O, Xiao D, Moore MA, Massagué J, Danishefsky SJ. Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog. Journal of the American Chemical Society. 132: 3224-8. PMID 20155906 DOI: 10.1021/Ja9101503  0.118
1978 Jacobsen N, Broxmeyer H, Grossbard E, Moore M. Diversity of human granulopoietic precursor cells: separation of cells that form colonies in diffusion chambers (CFU-d) from populations of colony-forming cells in vitro (CFU-c) by velocity sedimentation Blood. 52: 221-232. DOI: 10.1182/blood.v52.1.221.221  0.118
2005 Moldenhauer A, Shieh JH, Pruss A, Salama A, Moore MA. Tumor necrosis factor alpha enhances the adenoviral transduction of CD34+ hematopoietic progenitor cells. Stem Cells (Dayton, Ohio). 22: 283-91. PMID 15153606 DOI: 10.1634/stemcells.22-3-283  0.117
2006 Baughn LB, Di Liberto M, Wu K, Toogood P, Louie T, Gottschalk R, Niesvizky R, Cho HJ, Ely S, Moore MA, Chen-Kiang S. A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumor Growth by Specific Inhibition of Cdk4/6. Blood. 108: 369-369. DOI: 10.1182/Blood.V108.11.369.369  0.117
2017 Xiao S, Shterev ID, Zhang W, Young L, Shieh JH, Moore M, van den Brink M, Sempowski GD, Manley NR. Sublethal Total Body Irradiation Causes Long-Term Deficits in Thymus Function by Reducing Lymphoid Progenitors. Journal of Immunology (Baltimore, Md. : 1950). PMID 28931604 DOI: 10.4049/Jimmunol.1600934  0.117
2013 Moore MA. What and where for publications by cancer registries in the Asian Pacific? - roles for the APJCP in the future. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 4939-42. PMID 24083772 DOI: 10.7314/APJCP.2013.14.8.4939  0.117
1973 Moore MA, Williams N. Analysis of proliferation and differentiation of foetal granulocyte-macrophage progenitor cells in haemopoietic tissue. Cell and Tissue Kinetics. 6: 461-76. PMID 4201113 DOI: 10.1111/j.1365-2184.1973.tb01634.x  0.116
2014 Joyner J, Moore MA, Simmons DR, Forrest B, Yu-Isenberg K, Piccione R, Caton K, Lackland DT, Ferrario CM. Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative. The Journal of Continuing Education in the Health Professions. 34: 25-36. PMID 24648361 DOI: 10.1002/Chp.21217  0.116
1982 Mertelsmann R, Moore MA, Clarkson B. Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells. Haematology and Blood Transfusion. 26: 68-72. PMID 6947940 DOI: 10.1007/978-3-642-67984-1_10  0.116
1994 Gasparetto C, Smith C, Firpo M, Dennig D, Small T, Gillio AP, Lichtenberg R, O'Reilly RJ, Moore MA. Dyshematopoiesis in combined immune deficiency with congenital neutropenia. American Journal of Hematology. 45: 63-72. PMID 8250011 DOI: 10.1002/Ajh.2830450110  0.116
1974 Moore MA, Metcalf D. Cytogenetic analysis of human acute and chronic myeloid leukemic cells cloned in agar culture. International Journal of Cancer. 11: 143-52. PMID 4524548 DOI: 10.1002/Ijc.2910110117  0.116
2003 Barberi T, Klivenyi P, Calingasan NY, Lee H, Kawamata H, Loonam K, Perrier AL, Bruses J, Rubio ME, Topf N, Tabar V, Harrison NL, Beal MF, Moore MA, Studer L. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nature Biotechnology. 21: 1200-7. PMID 14502203 DOI: 10.1038/Nbt870  0.115
2014 Igissinov N, Kulmirzayeva D, Moore MA, Igissinov S, Baidosova G, Akpolatova G, Bukeyeva Z, Omralina Y. Epidemiological assessment of leukemia in Kazakhstan, 2003- 2012. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 6969-72. PMID 25169555  0.115
2006 Baughn LB, Di Liberto M, Wu K, Toogood PL, Louie T, Gottschalk R, Niesvizky R, Cho H, Ely S, Moore MA, Chen-Kiang S. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. Cancer Research. 66: 7661-7. PMID 16885367 DOI: 10.1158/0008-5472.Can-06-1098  0.115
1983 Ralph P, Harris P, Punjabi C, Welte K, Litcofsky P, Ho M, Rubin B, Moore M, Springer T. Lymphokine inducing "terminal differentiation" of the human monoblast leukemia line U937: a role for gamma interferon Blood. 62: 1169-1175. DOI: 10.1182/blood.v62.6.1169.1169  0.115
2015 Pera B, Calvo-Vidal MN, Ambati S, Jordi M, Kahn A, Díaz JF, Fang W, Altmann KH, Cerchietti L, Moore MA. High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells. Cancer Letters. 368: 97-104. PMID 26277539 DOI: 10.1016/j.canlet.2015.07.038  0.115
1990 Laver J, Abboud M, Gasparetto C, Gillio A, Smith C, O'Reilly RJ, Moore MA. Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy. Biotherapy (Dordrecht, Netherlands). 1: 293-300. PMID 2484306 DOI: 10.1007/Bf02171005  0.114
2013 Shaykhiev R, Wang R, Zwick RK, Hackett NR, Leung R, Moore MA, Sima CS, Chao IW, Downey RJ, Strulovici-Barel Y, Salit J, Crystal RG. Airway basal cells of healthy smokers express an embryonic stem cell signature relevant to lung cancer. Stem Cells (Dayton, Ohio). 31: 1992-2002. PMID 23857717 DOI: 10.1002/Stem.1459  0.114
1983 Lu L, Broxmeyer H, Meyers P, Moore M, Thaler H. Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins Blood. 61: 250-256. DOI: 10.1182/blood.V61.2.250.bloodjournal612250  0.114
1983 Lu L, Broxmeyer H, Meyers P, Moore M, Thaler H. Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins Blood. 61: 250-256. DOI: 10.1182/BLOOD.V61.2.250.250  0.114
1973 Moore MA, Williams N. Physical separation of colony stimulating cells from in vitro colony forming cells in hemopoietic tissue. Journal of Cellular Physiology. 80: 195-206. PMID 4629483 DOI: 10.1002/JCP.1040800206  0.114
1982 Steinmann G, Broxmeyer HE, de Harven E, Moore MA. Immuno-electron microscopic tracing of lactoferrin, a regulator of myelopoiesis, into a subpopulation of human peripheral blood monocytes. British Journal of Haematology. 50: 75-84. PMID 7034768 DOI: 10.1111/j.1365-2141.1982.tb01892.x  0.113
2018 Velardi E, Tsai JJ, Radtke S, Cooper K, Argyropoulos KV, Jae-Hung S, Young LF, Lazrak A, Smith OM, Lieberman S, Kreines F, Shono Y, Wertheimer T, Jenq RR, Hanash AM, ... ... Moore MA, et al. Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury. Nature Medicine. PMID 29309056 DOI: 10.1038/Nm.4470  0.113
1998 Deshpande RV, Peterson RH, Moore MA. Granulocyte colony-stimulating factor activates protein kinase A in granulocytic but not monocytic precursors or neutrophils. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 18: 579-86. PMID 9726439 DOI: 10.1089/JIR.1998.18.579  0.113
1998 Narumi K, Suzuki M, Song W, Moore MA, Crystal RG. Intermittent, Repetitive Corticosteroid-Induced Upregulation of Platelet Levels After Adenovirus-Mediated Transfer to the Liver of a Chimeric Glucocorticoid-Responsive Promoter Controlling the Thrombopoietin cDNA Blood. 92: 822-833. DOI: 10.1182/Blood.V92.3.822  0.112
1992 Moore MA. Selective protection of hematopoietic stem cells from chemotherapy Current Opinion in Oncology. 4: S49-S51. DOI: 10.1097/00001622-199212001-00017  0.112
1998 Narumi K, Suzuki M, Song W, Moore MA, Crystal RG. Intermittent, Repetitive Corticosteroid-Induced Upregulation of Platelet Levels After Adenovirus-Mediated Transfer to the Liver of a Chimeric Glucocorticoid-Responsive Promoter Controlling the Thrombopoietin cDNA Blood. 92: 822-833. DOI: 10.1182/blood.v92.3.822.415a16_822_833  0.112
2007 Huang X, Louie T, Di Liberto M, Rice J, Jayabalan D, Zhang K, Palladino M, Chen I, Toogood P, Niesvizky R, Moore MA, Chen-Kiang S. Targeting Cdk4/6 in Combination Therapy Overcomes Proteasome Inhibitor Resistance in Multiple Myeloma through Synergistic Mitochondria Depolarization. Blood. 110: 667-667. DOI: 10.1182/BLOOD.V110.11.667.667  0.112
2013 Wang Q, Cui K, Espin-Garcia O, Cheng D, Qiu X, Chen Z, Moore M, Bristow RG, Xu W, Der S, Liu G. Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis. Plos One. 8: e82363. PMID 24349265 DOI: 10.1371/Journal.Pone.0082363  0.111
2013 Igissinov N, Zatoskikh V, Moore MA, Igissinov S, Aldiyarova G, Tokmurziyeva G, Valieva S, Alpeissova S, Sarsenova S. Laryngeal cancer in Kazakhstan - ethnic, age and gender differences over time. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 7033-8. PMID 24377645 DOI: 10.7314/APJCP.2013.14.11.7033  0.11
2007 Chaudhury S, Barker J, de Baisre A, O’Reilly R, Moore MA. An Animal Model That Predicts Unit Engraftment in Double Unit Cord Blood Transplant Recipients. Blood. 110: 176-176. DOI: 10.1182/BLOOD.V110.11.176.176  0.11
1979 Ito M, Ralph P, Moore MA. In vitro stimulation of phagocytosis in a macrophage cell line measured by a convenient radiolabeled latex bead assay. Cellular Immunology. 46: 48-56. PMID 487443 DOI: 10.1016/0008-8749(79)90244-2  0.11
2012 Huang X, Di Liberto M, Jayabalan D, Liang J, Ely S, Bretz J, Shaffer AL, Louie T, Chen I, Randolph S, Hahn WC, Staudt LM, Niesvizky R, Moore MA, Chen-Kiang S. Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4. Blood. 120: 1095-106. PMID 22718837 DOI: 10.1182/Blood-2012-03-415984  0.109
2015 Yang C, Boyson CA, Di Liberto M, Huang X, Hannah J, Dorn DC, Moore MA, Chen-Kiang S, Zhou P. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. Cancer Research. 75: 1838-45. PMID 25744718 DOI: 10.1158/0008-5472.Can-14-2486  0.109
2022 Gianulis E, Wetzell B, Scheunemann D, Gazzolo P, Sohoni P, Moore MA, Chen J. Characterization of an advanced viable bone allograft with preserved native bone-forming cells. Cell and Tissue Banking. PMID 36434165 DOI: 10.1007/s10561-022-10044-2  0.109
2013 Ambati SR, Caldas Lopes E, Kosugi K, Mony U, Zehir A, Moreira AL, Meyers PA, Chiosis G, Moore MA. Activity of PU-H71, a novel HSP90 inhibitor, and bortezomib in Ewing sarcoma preclinical models. Journal of Clinical Oncology. 31: 3101-3101. DOI: 10.1200/Jco.2013.31.15_Suppl.3101  0.108
1977 Broxmeyer HE, Mendelsohn N, Moore MA. Abnormal granulocyte feedback regulation of colony forming and colony stimulating activity-producing cells from patients with chronic myelogenous leukemia Leukemia Research. 1: 3-12. DOI: 10.1016/0145-2126(77)90059-5  0.108
1981 Steinmann G, Mertelsmann R, deHarven E, Moore M. Ultrastructural demonstration of terminal deoxynucleotidyl transferase (TdT) Blood. 57: 368-371. DOI: 10.1182/BLOOD.V57.2.368.BLOODJOURNAL572368  0.108
2013 Moore MA. Overview of cancer registration research in the Asian Pacific from 2008-2013. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 4461-84. PMID 24083689 DOI: 10.7314/APJCP.2013.14.8.4461  0.108
1981 Steinmann G, Mertelsmann R, deHarven E, Moore M. Ultrastructural demonstration of terminal deoxynucleotidyl transferase (TdT) Blood. 57: 368-371. DOI: 10.1182/blood.v57.2.368.368  0.108
1984 Kruger G, Welte K, Ciobanu N, Cunningham-Rundles C, Ralph P, Venuta S, Feldman S, Koziner B, Wang CY, Moore MA. Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency. Journal of Clinical Immunology. 4: 295-303. PMID 6611349 DOI: 10.1007/BF00915297  0.108
1983 Feldman S, Mertelsmann R, Venuta S, Andreeff M, Welte K, Moore M. Sodium azide enhancement of interleukin-2 production Blood. 61: 815-818. DOI: 10.1182/Blood.V61.4.815.815  0.107
2010 Salim EI, Moore MA, Bener A, Habib OS, Seif-Eldin IA, Sobue T. Cancer epidemiology in South-West Asia - past, present and future. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 33-48. PMID 20553067  0.107
1997 Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MA, Dmitrovsky E. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Differentiation; Research in Biological Diversity. 61: 321-31. PMID 9342843 DOI: 10.1046/J.1432-0436.1997.6150321.X  0.106
2016 Villasante A, Marturano-Kruik A, Ambati SR, Liu Z, Godier-Furnemont A, Parsa H, Lee BW, Moore MA, Vunjak-Novakovic G. Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model. Theranostics. 6: 1119-30. PMID 27279906 DOI: 10.7150/Thno.13944  0.106
1997 Albanell J, Lonardo F, Rusch V, Engelhardt M, Langenfeld J, Han W, Klimstra D, Venkatraman E, Moore MA, Dmitrovsky E. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. Journal of the National Cancer Institute. 89: 1609-15. PMID 9362159 DOI: 10.1093/Jnci/89.21.1609  0.106
2013 Wang P, Dong S, Shieh JH, Peguero E, Hendrickson R, Moore MA, Danishefsky SJ. Erythropoietin derived by chemical synthesis. Science (New York, N.Y.). 342: 1357-60. PMID 24337294 DOI: 10.1126/Science.1245095  0.106
1979 Moore MA. Interpretations of culture data in aplastic anemia: evidence for a suppressor cell involvement Hamatologie Und Bluttransfusion. 24: 265-271. PMID 161538 DOI: 10.1007/978-3-642-67483-9_34  0.105
2006 Wen VW, Wu K, Baksh S, Hinshelwood RA, Lock RB, Clark SJ, Moore MA, Mackenzie KL. Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells. Cancer Research. 66: 10691-700. PMID 17108106 DOI: 10.1158/0008-5472.CAN-06-0979  0.105
2021 Perston YL, Moore M, Suryatman, Langley M, Hakim B, Oktaviana AA, Brumm A. A standardised classification scheme for the Mid-Holocene Toalean artefacts of South Sulawesi, Indonesia. Plos One. 16: e0251138. PMID 34038416 DOI: 10.1371/journal.pone.0251138  0.105
1997 Song W, Kong HL, Carpenter H, Torii H, Granstein R, Rafii S, Moore MA, Crystal RG. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. The Journal of Experimental Medicine. 186: 1247-56. PMID 9334364 DOI: 10.1084/Jem.186.8.1247  0.105
2015 Lloyd KC, Meehan T, Beaudet A, Murray S, Svenson K, McKerlie C, West D, Morse I, Parkinson H, Brown S, Mallon AM, Moore M. Precision medicine: Look to the mice. Science (New York, N.Y.). 349: 390. PMID 26206923 DOI: 10.1126/Science.349.6246.390-A  0.104
1987 Steinberg J, Moore MA, Bona CA, Benjamin WR, Farrar JJ, Familletti PC, Platsoucas CD. Inhibition of spontaneous proliferation of human leukemic B cells from patients with chronic lymphocytic leukemia by anti-mu antibodies. Clinical Immunology and Immunopathology. 44: 371-80. PMID 3113786 DOI: 10.1016/0090-1229(87)90081-X  0.103
2003 Wu KD, Orme LM, Shaughnessy J, Jacobson J, Barlogie B, Moore MA. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood. 101: 4982-9. PMID 12609839 DOI: 10.1182/BLOOD-2002-11-3451  0.103
2013 Igissinov N, Zatoskikh V, Moore MA, Igissinov S, Toulebaeyev R, Mustafina M, Valieva S, Aldiyarova G, Bukeyeva Z, Venglovskiy A. Epidemiological evaluation of laryngeal cancer incidence in Kazakhstan for the years 1999-2009. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 3969-74. PMID 23886216 DOI: 10.7314/APJCP.2013.14.6.3969  0.103
1984 Welte K, Ciobanu N, Moore M, Gulati S, O'Reilly R, Mertelsmann R. Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2 Blood. 64: 380-385. DOI: 10.1182/blood.V64.2.380.bloodjournal642380  0.102
2010 Long N, Moore MA, Chen W, Gao CM, Lai MS, Mizoue T, Oyunchimeg D, Park S, Shin HR, Tajima K, Yoo KY, Sobue T. Cancer epidemiology and control in north-East Asia - past, present and future. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 107-48. PMID 20553072  0.101
2010 Moore MA, Eser S, Igisinov N, Igisinov S, Mohagheghi MA, Mousavi-Jarrahi A, Ozentürk G, Soipova M, Tuncer M, Sobue T. Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 17-32. PMID 20553066  0.101
2015 Thinkhamrop K, Khuntikeo N, Phonjitt P, Chamadol N, Thinkhamrop B, Moore MA, Promthet S. Association between Diabetes Mellitus and Fatty Liver Based on Ultrasonography Screening in the World's Highest Cholangiocarcinoma Incidence Region, Northeast Thailand. Asian Pacific Journal of Cancer Prevention : Apjcp. 16: 3931-6. PMID 25987063 DOI: 10.7314/APJCP.2015.16.9.3931  0.101
2013 Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Imai K, Hayashi T, Nakachi K, Young LF, Moore MA, van den Brink MR, Kusunoki Y. Age-associated changes in the differentiation potentials of human circulating hematopoietic progenitors to T- or NK-lineage cells. Journal of Immunology (Baltimore, Md. : 1950). 190: 6164-72. PMID 23670190 DOI: 10.4049/jimmunol.1203189  0.101
1978 Mertelsmann R, Mertelsmann I, Koziner B, Moore MA, Clarkson BD. Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phase Leukemia Research. 2: 57-69. DOI: 10.1016/0145-2126(78)90007-3  0.1
2004 Lanza R, Moore MA, Wakayama T, Perry AC, Shieh JH, Hendrikx J, Leri A, Chimenti S, Monsen A, Nurzynska D, West MD, Kajstura J, Anversa P. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circulation Research. 94: 820-7. PMID 14764454 DOI: 10.1161/01.Res.0000120863.53562.Df  0.1
1988 Wang S, Ho C, Chen L, Wang R, Huang M, Castro-Malaspina H, Moore M. Down regulation of myelopoiesis by mediators inhibiting the production of macrophage-derived granulomonopoietic enhancing activity (GM-EA) Blood. 72: 2001-2006. DOI: 10.1182/blood.v72.6.2001.2001  0.1
2012 Igissinov S, Igissinov N, Moore MA, Kalieva Z, Kozhakhmetov S. Epidemiology of esophageal cancer in Kazakhstan. Asian Pacific Journal of Cancer Prevention : Apjcp. 13: 833-6. PMID 22631657 DOI: 10.7314/APJCP.2012.13.3.833  0.1
1988 Wang S, Ho C, Chen L, Wang R, Huang M, Castro-Malaspina H, Moore M. Down regulation of myelopoiesis by mediators inhibiting the production of macrophage-derived granulomonopoietic enhancing activity (GM-EA) Blood. 72: 2001-2006. DOI: 10.1182/BLOOD.V72.6.2001.BLOODJOURNAL7262001  0.1
2006 Zhang J, Shieh J, Liu L, Plasilova M, Zhang Y, Morrone G, Moore MA, Zhou P. Ubiquitin-Proteolytic Control of HOX Homeodomain Proteins. Blood. 108: 1121-1121. DOI: 10.1182/blood.v108.11.1121.1121  0.1
1980 Mertelsmann R, Koziner B, Filippa DA, Grossbard E, Incefy G, Moore MA, Clarkson BD. Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias. Haematology and Blood Transfusion. 23: 131-8. PMID 317470 DOI: 10.1007/978-3-642-67057-2_16  0.1
1973 Williams N, Moore M. Sedimentation velocity characterisation of the cell cycle of granulocytic progenitor cells in monkey hemopoietic tissue. Journal of Cellular Physiology. 82: 81-92. PMID 4199660 DOI: 10.1002/JCP.1040820110  0.099
2015 Ashbridge B, Zehir A, Lubin M, Barker JN, Moore MA. Evaluation of Initial Telomere Length and Changes after Transplantation in Adult Double-Unit Cord Blood Transplant Recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1334-6. PMID 25865647 DOI: 10.1016/j.bbmt.2015.04.006  0.099
1984 Gold EJ, Conjalka M, Pelus LM, Jhanwar SC, Broxmeyer H, Middleton AB, Clarkson BD, Moore MA. Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 1: 627-34. PMID 6583316 DOI: 10.1200/Jco.1983.1.10.627  0.099
2014 Moore MA. Cancer control programs in East Asia: evidence from the international literature. Journal of Preventive Medicine and Public Health = Yebang å¬Ihakhoe Chi. 47: 183-200. PMID 25139165 DOI: 10.3961/jpmph.2014.47.4.183  0.099
2015 Hallett PJ, Deleidi M, Astradsson A, Smith GA, Cooper O, Osborn TM, Sundberg M, Moore MA, Perez-Torres E, Brownell AL, Schumacher JM, Spealman RD, Isacson O. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease. Cell Stem Cell. 16: 269-74. PMID 25732245 DOI: 10.1016/J.Stem.2015.01.018  0.098
2002 Takebe N, Xu LC, MacKenzie KL, Bertino JR, Moore MA. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene. Cancer Gene Therapy. 9: 308-20. PMID 11896448 DOI: 10.1038/sj.cgt.7700443  0.098
2015 Moore MA, Samsell B, Wallis G, Triplett S, Chen S, Jones AL, Qin X. Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review. Cell and Tissue Banking. 16: 249-59. PMID 25163609 DOI: 10.1007/s10561-014-9467-4  0.098
2018 Kajimura J, Kyoizumi S, Kubo Y, Misumi M, Yoshida K, Hayashi T, Imai K, Ohishi W, Nakachi K, Weng NP, Young LF, Shieh JH, Moore MA, van den Brink MRM, Kusunoki Y. Corrigendum to "Relationship between spontaneous γH2AX foci formation and progenitor functions in circulating hematopoietic stem and progenitor cells among atomic-bomb survivors" [Mutat. Res. - Genet. Toxicol. Environ. Mutagen. 802 (2016) 59-65]. Mutation Research. 827: 68. PMID 29502739 DOI: 10.1016/j.mrgentox.2017.11.003  0.098
1984 Ciobanu N, Welte K, Kruger G, Venuta S, Gold J, Feldman SP, Wang CY, Koziner B, Moore MA, Safai B. Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2. Journal of Clinical Immunology. 3: 332-40. PMID 6606643 DOI: 10.1007/BF00915794  0.098
2000 Kikuchi T, Worgall S, Singh R, Moore MA, Crystal RG. Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells. Nature Medicine. 6: 1154-9. PMID 11017148 DOI: 10.1038/80498  0.097
1970 Haskill JS, McNeill TA, Moore MA. Density distribution analysis of in vivo and in vitro colony forming cells in bone marrow. Journal of Cellular Physiology. 75: 167-79. PMID 4908795 DOI: 10.1002/JCP.1040750206  0.097
2010 Bener A, Moore MA, Ali R, El Ayoubi HR. Impacts of family history and lifestyle habits on colorectal cancer risk: a case-control study in Qatar. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 963-8. PMID 21133608  0.097
2016 Rakkapao N, Promthet S, Moore MA, Hurst CP. Development of a breast cancer awareness scale for Thai women: Moving towards a validated measure Asian Pacific Journal of Cancer Prevention. 17: 851-856. DOI: 10.7314/APJCP.2016.17.2.851  0.096
2003 Zhang Y, Morrone G, Zhang J, Chen X, Lu X, Ma L, Moore M, Zhou P. CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. The Embo Journal. 22: 6057-67. PMID 14609952 DOI: 10.1093/Emboj/Cdg577  0.096
2014 David MS, Kelly E, Cheung I, Xaymardan M, Moore MA, Zoellner H. SAOS-2 osteosarcoma cells bind fibroblasts via ICAM-1 and this is increased by tumour necrosis factor-α. Plos One. 9: e101202. PMID 24979620 DOI: 10.1371/journal.pone.0101202  0.095
1997 Cannizzo SJ, Frey BM, Raffi S, Moore MA, Eaton D, Suzuki M, Singh R, Mack CA, Crystal RG. Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA. Nature Biotechnology. 15: 570-3. PMID 9181581 DOI: 10.1038/Nbt0697-570  0.095
2018 Cole W, Samsell B, Moore MA. Achilles Tendon Augmented Repair Using Human Acellular Dermal Matrix: A Case Series. The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons. PMID 29779989 DOI: 10.1053/j.jfas.2018.03.006  0.094
2015 Kaja S, Payne AJ, Naumchuk Y, Levy D, Zaidi DH, Altman AM, Nawazish S, Ghuman JK, Gerdes BC, Moore MA, Koulen P. Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes. Experimental Eye Research. PMID 26048476 DOI: 10.1016/J.Exer.2015.05.023  0.094
2011 Lecomte N, Njardarson JT, Nagorny P, Yang G, Downey R, Ouerfelli O, Moore MA, Danishefsky SJ. Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin. Proceedings of the National Academy of Sciences of the United States of America. 108: 15074-8. PMID 21808037 DOI: 10.1073/Pnas.1015247108  0.094
2021 Berens AS, Palmer T, Dutton ND, Lavery A, Moore M. Using search-constrained inverse distance weight modeling for near real-time riverine flood modeling: Harris County, Texas, USA before, during, and after Hurricane Harvey. Natural Hazards (Dordrecht, Netherlands). 105: 277-292. PMID 34092916 DOI: 10.1007/s11069-020-04309-w  0.093
2016 Kajimura J, Kyoizumi S, Kubo Y, Misumi M, Yoshida K, Hayashi T, Imai K, Ohishi W, Nakachi K, Weng NP, Young LF, Shieh JH, Moore MA, van den Brink MR, Kusunoki Y. Relationship between spontaneous γH2AX foci formation and progenitor functions in circulating hematopoietic stem and progenitor cells among atomic-bomb survivors. Mutation Research. Genetic Toxicology and Environmental Mutagenesis. 802: 59-65. PMID 27169377 DOI: 10.1016/j.mrgentox.2016.04.006  0.093
2012 Moore MA, Perry SD. Oughts v. ends: Seeking an ethical normative standard for journal acceptance rate calculation methods Journal of Academic Ethics. 10: 113-121. DOI: 10.1007/s10805-012-9158-3  0.092
2013 Igissinov S, Igissinov N, Moore MA, Kozhakhmetov S, Igissinova G, Sarsenova S, Aldiyarova G, Bilyalova Z, Zhabagin K, Manambayeva Z. Component analysis of esophageal cancer incidence in Kazakhstan. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 1945-9. PMID 23679297 DOI: 10.7314/APJCP.2013.14.3.1945  0.092
2003 Sommer G, Agosti V, Ehlers I, Rossi F, Corbacioglu S, Farkas J, Moore M, Manova K, Antonescu CR, Besmer P. Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase. Proceedings of the National Academy of Sciences of the United States of America. 100: 6706-11. PMID 12754375 DOI: 10.1073/Pnas.1037763100  0.092
1998 Deshpande RV, Moore MA. G-CSF receptor-mediated up-regulation of c-fos but not c-raf mRNA expression in myeloid cells. Molecular and Cellular Biochemistry. 178: 47-50. PMID 9546580 DOI: 10.1023/A:1006894329316  0.091
2014 Gupta K, Kuznetsova I, Klimenkova O, Klimiankou M, Meyer J, Moore MA, Zeidler C, Welte K, Skokowa J. Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells. Blood. 123: 2550-61. PMID 24394665 DOI: 10.1182/blood-2012-09-456889  0.091
1996 Ohwada A, Rafii S, Moore M, Crystal R. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy- induced bone marrow suppression Blood. 88: 778-784. DOI: 10.1182/blood.v88.3.778.bloodjournal883778  0.09
2004 Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, Nana-Sinkam SP, Voelkel NF, Geraci MW. Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine. 170: 911-9. PMID 15215156 DOI: 10.1164/Rccm.200312-1686Oc  0.09
1995 Fennelly D, Schneider J, Spriggs D, Bengala C, Hakes T, Reich L, Barakat R, Curtin J, Moore MA, Hoskins W. Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 13: 1160-6. PMID 7537799 DOI: 10.1200/JCO.1995.13.5.1160  0.09
2011 Schofield PN, Dubus P, Klein L, Moore M, McKerlie C, Ward JM, Sundberg JP. Pathology of the laboratory mouse: an International Workshop on Challenges for High Throughput Phenotyping. Toxicologic Pathology. 39: 559-62. PMID 21444746 DOI: 10.1177/0192623311399789  0.089
2011 Promthet S, Saranrittichai K, Kamsa-ard S, Senarak W, Vatanasapt P, Wiangnon S, Wongphuthorn P, Moore MA. Situation analysis of risk factors related to non-communicable diseases in Khon Kaen Province, Thailand. Asian Pacific Journal of Cancer Prevention : Apjcp. 12: 1337-40. PMID 21875293  0.089
2017 Meehan TF, Conte N, West DB, Jacobsen JO, Mason J, Warren J, Chen CK, Tudose I, Relac M, Matthews P, Karp N, Santos L, Fiegel T, Ring N, Westerberg H, ... ... Moore M, et al. Disease model discovery from 3,328 gene knockouts by The International Mouse Phenotyping Consortium. Nature Genetics. PMID 28650483 DOI: 10.1038/Ng.3901  0.089
2011 Dogan Y, Sahay S, Dorn DC, Franceschino A, Xu M, Moore MA. The Nup98-HoxA9 Leukemogenic Fusion Protein Blocks Xpo1 and Tap-Mediated Nuclear Export Blood. 118: 5228-5228. DOI: 10.1182/blood.v118.21.5228.5228  0.089
2008 Bull TM, Meadows CA, Coldren CD, Moore M, Sotto-Santiago SM, Nana-Sinkam SP, Campbell TB, Geraci MW. Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells. American Journal of Respiratory Cell and Molecular Biology. 39: 706-16. PMID 18587055 DOI: 10.1165/rcmb.2007-0368OC  0.088
2000 Lane WJ, Dias S, Hattori K, Heissig B, Choy M, Rabbany SY, Wood J, Moore MA, Rafii S. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood. 96: 4152-9. PMID 11110686 DOI: 10.1182/Blood.V96.13.4152.H8004152_4152_4159  0.088
2015 Graham RS, Samsell BJ, Proffer A, Moore MA, Vega RA, Stary JM, Mathern B. Evaluation of glycerol-preserved bone allografts in cervical spine fusion: a prospective, randomized controlled trial. Journal of Neurosurgery. Spine. 22: 1-10. PMID 25360528 DOI: 10.3171/2014.9.Spine131005  0.088
1998 Möhle R, Salemi P, Moore MA, Rafii S. Expression of interleukin-5 by human bone marrow microvascular endothelial cells: implications for the regulation of eosinophilopoiesis in vivo. British Journal of Haematology. 99: 732-8. PMID 9432015 DOI: 10.1046/J.1365-2141.1997.4713279.X  0.086
2023 May A, Richards C, Moore M. Measuring the Change in Soft Palate Length and Shape Following Maxillary Advancement: A Cohort Study in Patients with Orofacial Clefts. The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association. 10556656231175860. PMID 37170555 DOI: 10.1177/10556656231175860  0.086
2013 Sutton JT, Glenton PN, Fittall ME, Moore MA, Box D. Reservoir simulation to investigate the effect of flow baffles in a Basin-Floor Fan, Scarborough Field, North West Shelf, Australia Spe Middle East Oil and Gas Show and Conference, Meos, Proceedings. 2: 1010-1017.  0.086
2016 Robinson JF, Godfrey MJ, Moore MA. Glasslike behavior of a hard-disk fluid confined to a narrow channel. Physical Review. E. 93: 032101. PMID 27078286 DOI: 10.1103/PhysRevE.93.032101  0.086
2004 Gaul C, Njardarson JT, Shan D, Dorn DC, Wu KD, Tong WP, Huang XY, Moore MA, Danishefsky SJ. The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. Journal of the American Chemical Society. 126: 11326-37. PMID 15355116 DOI: 10.1021/Ja048779Q  0.085
2012 Saranrittichai K, Senarak W, Promthet S, Wiangnon S, Vatanasapt P, Kamsa-Ard S, Wongphuthorn P, Moore MA. Health behavior after a multiprofessional intervention and training for ongoing volunteer-based community health programme intervention in the North-East of Thailand: what changed and what not? Asian Pacific Journal of Cancer Prevention : Apjcp. 13: 4801-5. PMID 23167423 DOI: 10.7314/APJCP.2012.13.9.4801  0.085
2010 Moore MA, Attasara P, Khuhaprema T, Le TN, Nguyen TH, Raingsey PP, Sriamporn S, Sriplung H, Srivanatanakul P, Bui DT, Wiangnon S, Sobue T. Cancer epidemiology in mainland South-East Asia - past, present and future. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 67-80. PMID 20553069  0.083
2012 Samsell BJ, Moore MA. Use of controlled low dose gamma irradiation to sterilize allograft tendons for ACL reconstruction: biomechanical and clinical perspective. Cell and Tissue Banking. 13: 217-23. PMID 21431365 DOI: 10.1007/s10561-011-9251-7  0.083
1993 Shieh J, Gordon M, Jakubowski A, Peterson R, Gabrilove J, Moore M. Interleukin-1 modulation of cytokine receptors on human neutrophils: in vitro and in vivo studies Blood. 81: 1745-1754. DOI: 10.1182/BLOOD.V81.7.1745.BLOODJOURNAL8171745  0.083
1986 Lu L, Pelus L, Broxmeyer H, Moore M, Wachter M, Walker D, Platzer E. Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8- positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E Blood. 68: 126-133. DOI: 10.1182/blood.V68.1.126.bloodjournal681126  0.082
1983 Moore MA, Gabrilove J, Sheridan AP. Myeloid leukemic cell differentiation induced by human postendotoxin serum and vitamin analogues. Haematology and Blood Transfusion. 28: 327-37. PMID 6574954 DOI: 10.1007/978-3-642-68761-7_63  0.082
2017 Bertasi G, Cole W, Samsell B, Qin X, Moore M. Biological incorporation of human acellular dermal matrix used in Achilles tendon repair. Cell and Tissue Banking. PMID 28455604 DOI: 10.1007/s10561-017-9628-3  0.082
2004 Iigo M, Shimamura M, Matsuda E, Fujita K, Nomoto H, Satoh J, Kojima S, Alexander DB, Moore MA, Tsuda H. Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. Cytokine. 25: 36-44. PMID 14687584 DOI: 10.1016/J.CYTO.2003.09.009  0.082
1989 Gasparetto C, Laver J, Abboud M, Gillio A, Smith C, O'Reilly R, Moore M. Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model Blood. 74: 547-550. DOI: 10.1182/blood.v74.2.547.547  0.08
1989 Gasparetto C, Laver J, Abboud M, Gillio A, Smith C, O'Reilly R, Moore M. Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model Blood. 74: 547-550. DOI: 10.1182/Blood.V74.2.547.Bloodjournal742547  0.08
2001 Moore MA. The role of chemoattraction in cancer metastases. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 23: 674-6. PMID 11494314 DOI: 10.1002/BIES.1095  0.079
2015 Fernández-Tejada A, Brailsford J, Zhang Q, Shieh JH, Moore MA, Danishefsky SJ. Total synthesis of glycosylated proteins. Topics in Current Chemistry. 362: 1-26. PMID 25805144 DOI: 10.1007/128_2014_622  0.079
2011 Salim EI, Jazieh AR, Moore MA. Lung cancer incidence in the arab league countries: risk factors and control. Asian Pacific Journal of Cancer Prevention : Apjcp. 12: 17-34. PMID 21517227  0.079
2002 Moore MA. Putting the neo into neoangiogenesis. The Journal of Clinical Investigation. 109: 313-5. PMID 11827990 DOI: 10.1172/JCI14940  0.079
1986 Moore MA. Biologicals for cancer treatment: growth and differentiating agents. Hospital Practice (Office Ed.). 21: 69-80. PMID 3081537 DOI: 10.1080/21548331.1986.11706569  0.078
2012 Bosbach B, Deshpande S, Rossi F, Shieh JH, Sommer G, de Stanchina E, Veach DR, Scandura JM, Manova-Todorova K, Moore MA, Antonescu CR, Besmer P. Imatinib resistance and microcytic erythrocytosis in a KitV558Δ;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor. Proceedings of the National Academy of Sciences of the United States of America. 109: E2276-83. PMID 22652566 DOI: 10.1073/Pnas.1115240109  0.078
1970 Moore MA, McNeill TA, Haskill JS. Density distribution analysis of in vivo and in vitro colony forming cells in developing fetal liver. Journal of Cellular Physiology. 75: 181-92. PMID 5438056 DOI: 10.1002/JCP.1040750207  0.078
2012 Bradley A, Anastassiadis K, Ayadi A, Battey JF, Bell C, Birling MC, Bottomley J, Brown SD, Bürger A, Bult CJ, Bushell W, Collins FS, Desaintes C, Doe B, Economides A, ... ... Moore M, et al. The mammalian gene function resource: the International Knockout Mouse Consortium. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 23: 580-6. PMID 22968824 DOI: 10.1007/S00335-012-9422-2  0.078
1978 Mertelsmann R, Koziner B, Moore M. TdT activity in B cell ALL [letter] Blood. 52: 638-639. DOI: 10.1182/BLOOD.V52.3.638.638  0.077
2004 Anderson PJ, Netherway DJ, Abbott A, Moore M, David DJ. Mandibular lengthening by distraction for airway obstruction in treacher-collins syndrome: the long-term results. The Journal of Craniofacial Surgery. 15: 47-50. PMID 14704562 DOI: 10.1097/00001665-200401000-00015  0.077
2010 Moore MA, Baumann F, Foliaki S, Goodman MT, Haddock R, Maraka R, Koroivueta J, Roder D, Vinit T, Whippy HJ, Sobue T. Cancer epidemiology in the pacific islands - past, present and future. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 99-106. PMID 20553071  0.077
2011 Scioneaux AN, Schmidt MA, Moore MA, Lindroth RL, Wooley SC, Hagerman AE. Qualitative variation in proanthocyanidin composition of Populus species and hybrids: genetics is the key. Journal of Chemical Ecology. 37: 57-70. PMID 21116841 DOI: 10.1007/S10886-010-9887-Y  0.076
2013 Boardman AE, Laurin C, Moore MA, Vining AR. Efficiency, profitability and welfare gains from the Canadian National Railway privatization Research in Transportation Business and Management. 6: 19-30. DOI: 10.1016/J.Rtbm.2012.11.011  0.075
1989 Moore MA. Role of interleukin-1 in hematopoiesis. Immunologic Research. 8: 165-75. PMID 2473152 DOI: 10.1007/BF02918142  0.074
2016 Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu H, Baker CN, Bower L, Brown JM, Caddle LB, Chiani F, ... ... Moore M, et al. High-throughput discovery of novel developmental phenotypes. Nature. PMID 27626380 DOI: 10.1038/Nature19356  0.073
2016 Ferguson NL, Peña-Castillo L, Moore MA, Bignell DR, Tahlan K. Proteomics analysis of global regulatory cascades involved in clavulanic acid production and morphological development in Streptomyces clavuligerus. Journal of Industrial Microbiology & Biotechnology. PMID 26790415 DOI: 10.1007/s10295-016-1733-y  0.073
2019 Samsell B, Softic D, Qin X, McLean J, Sohoni P, Gonzales K, Moore MA. Preservation of allograft bone using a glycerol solution: a compilation of original preclinical research. Biomaterials Research. 23: 5. PMID 30805200 DOI: 10.1186/s40824-019-0154-1  0.073
2020 Wetzell B, McLean JB, Moore MA, Kondragunta V, Dorsch K. A large database study of hospitalization charges and follow-up re-admissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2). Journal of Orthopaedic Surgery and Research. 15: 544. PMID 33213484 DOI: 10.1186/s13018-020-02078-7  0.073
2012 Tajima K, Moore MA, Tsuda H. The contribution of Asian countries to the international cancer prevention effort - Reflections from a Glance at the literature Asian Pacific Journal of Cancer Prevention. 3: 1-2.  0.072
2010 Moore MA, Ariyaratne Y, Badar F, Bhurgri Y, Datta K, Mathew A, Gangadharan P, Nandakumar A, Pradhananga KK, Talukder MH, Yeole BB, Sobue T. Cancer epidemiology in South Asia - past, present and future. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 49-66. PMID 20553068  0.072
2012 Moore MA. Inactivation of enveloped and non-enveloped viruses on seeded human tissues by gamma irradiation. Cell and Tissue Banking. 13: 401-7. PMID 21809182 DOI: 10.1007/s10561-011-9266-0  0.072
2008 Balsly CR, Cotter AT, Williams LA, Gaskins BD, Moore MA, Wolfinbarger L. Effect of low dose and moderate dose gamma irradiation on the mechanical properties of bone and soft tissue allografts. Cell and Tissue Banking. 9: 289-98. PMID 18431690 DOI: 10.1007/S10561-008-9069-0  0.071
2018 Rozman J, Rathkolb B, Oestereicher MA, Schütt C, Ravindranath AC, Leuchtenberger S, Sharma S, Kistler M, Willershäuser M, Brommage R, Meehan TF, Mason J, Haselimashhadi H, Hough T, ... ... Moore M, et al. Identification of genetic elements in metabolism by high-throughput mouse phenotyping. Nature Communications. 9: 288. PMID 29348434 DOI: 10.1038/S41467-017-01995-2  0.071
2021 Wetzell B, McLean JB, Dorsch K, Moore MA. A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2). Journal of Orthopaedic Surgery and Research. 16: 680. PMID 34794470 DOI: 10.1186/s13018-021-02829-0  0.07
2011 Igissinov N, Igissinov S, Moore MA, Shaidarov M, Tereshkevich D, Bilyalova Z, Igissinova G, Nuralina I, Kozhakhmetov S. Trends of prevalent cancer incidences in the Aral-Syr Darya ecological area of Kazakhstan. Asian Pacific Journal of Cancer Prevention : Apjcp. 12: 2299-303. PMID 22296374  0.069
2009 Zheng X, Oancea C, Henschler R, Moore MA, Ruthardt M. Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment. Plos One. 4: e7661. PMID 19876398 DOI: 10.1371/journal.pone.0007661  0.069
2004 Agosti V, Corbacioglu S, Ehlers I, Waskow C, Sommer G, Berrozpe G, Kissel H, Tucker CM, Manova K, Moore MA, Rodewald HR, Besmer P. Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. The Journal of Experimental Medicine. 199: 867-78. PMID 15024050 DOI: 10.1084/Jem.20031983  0.069
1999 Moore MA, MacKenzie KL. Optimizing conditions for gene transfer into human hematopoietic cells. Progress in Experimental Tumor Research. 36: 20-49. PMID 10386063 DOI: 10.1159/000061987  0.069
2007 Lee G, Kim BS, Shieh J, Moore MA. Enforced Expression of BMI-1 in Postnatal Human CD34+ Cells Promotes Erythroid Differentiation The Korean Journal of Hematology. 42: 241. DOI: 10.5045/Kjh.2007.42.3.241  0.067
2017 Cazzell S, Vayser D, Pham H, Walters J, Reyzelman A, Samsell B, Dorsch K, Moore M. A Randomized Clinical Trial of a Human Acellular Dermal Matrix Demonstrated Superior Healing Rates for Chronic Diabetic Foot Ulcers over Conventional Care and an Active Acellular Dermal Matrix Comparator. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. PMID 28544150 DOI: 10.1111/wrr.12551  0.067
1984 Welte K, Andreeff M, Platzer E, Holloway K, Rubin BY, Moore MA, Mertelsmann R. Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes. The Journal of Experimental Medicine. 160: 1390-403. PMID 6092510 DOI: 10.1084/Jem.160.5.1390  0.066
1978 Williams N, Jackson H, Sheridan AP, Murphy MJ, Elste A, Moore MA. Regulation of megakaryopoiesis in long-term murine bone marrow cultures. Blood. 51: 245-55. PMID 620084  0.066
2012 Promthet S, Wiangnon S, Senarak W, Saranrittichai K, Vatanasapt P, Kamsa-ard S, Wongphuthorn P, Kasinpila C, Moore MA. Evaluation of health education in the Multi-professional Intervention and Training for Ongoing Volunteer-based Community Health Programme in the north-east of Thailand. Asian Pacific Journal of Cancer Prevention : Apjcp. 13: 1753-5. PMID 22901116 DOI: 10.7314/APJCP.2012.13.5.1753  0.065
2010 Morozov A, Leversha M, Keohan M, D'Adamo DR, Schwartz GK, Meyers PA, Maki RG, Moore MA. Direct visualization of circulating sarcoma cells by whole-blood fluorescence in situ hybridization. Journal of Clinical Oncology. 28: 10637-10637. DOI: 10.1200/jco.2010.28.15_suppl.10637  0.065
2020 Shahrdar C, McLean J, Gianulis E, Softic D, Qin X, Moore MA, Chen J. Clinical outcome and explant histology after using a cellular bone allograft in two-stage total hip arthroplasty. Journal of Orthopaedic Surgery and Research. 15: 16. PMID 31948445 DOI: 10.1186/S13018-020-1542-X  0.064
2007 Stone M, McGuire L, Moore M, Hamilton D, Weinstein S. Test and teach. Number 39. Diagnosis: Rhinoscleroma. Pathology. 39: 516-8. PMID 17886103 DOI: 10.1080/00313020701569931  0.064
2011 Igissinov N, Tereshkevich D, Moore MA, Igissinov S, Shaidarov M, Bilyalova Z, Igissinova G, Nuralina I, Kozhakhmetov S, Mauyenova D. Age characteristics of incidences of prevalent cancers in the Aral Sea area of Kazakhstan. Asian Pacific Journal of Cancer Prevention : Apjcp. 12: 2295-7. PMID 22296373  0.064
2014 Moore MA, Sangrajrang S, Bray F. Asian Cancer Registry Forum 2014 - regional cooperation for cancer registration: priorities and challenges. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 1891-4. PMID 24716906  0.063
2018 Moore BA, Leonard BC, Sebbag L, Edwards SG, Cooper A, Imai DM, Straiton E, Santos L, Reilly C, Griffey SM, Bower L, Clary D, Mason J, Roux MJ, Meziane H, ... ... Moore M, et al. Identification of genes required for eye development by high-throughput screening of mouse knockouts. Communications Biology. 1: 236. PMID 30588515 DOI: 10.1038/s42003-018-0226-0  0.062
2003 Wiltshire E, Moore M, Casey T, Smith G, Smith S, Thompson E. Fryns "Anophthalmia-Plus" syndrome associated with developmental regression. Clinical Dysmorphology. 12: 41-3. PMID 12514364 DOI: 10.1097/00019605-200301000-00007  0.061
2019 Hall JF, McLean JB, Jones SM, Moore MA, Nicholson MD, Dorsch KA. Multilevel instrumented posterolateral lumbar spine fusion with an allogeneic cellular bone graft. Journal of Orthopaedic Surgery and Research. 14: 372. PMID 31730007 DOI: 10.1186/s13018-019-1424-2  0.06
2012 Moore MA, Barber KR, Britt T. Tetanus seropositive prevalence and perceived protection from emergency admissions. Emerging Health Threats Journal. 5. PMID 22461848 DOI: 10.3402/ehtj.v5i0.7718  0.06
2014 Godfrey MJ, Moore MA. Static and dynamical properties of a hard-disk fluid confined to a narrow channel. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 89: 032111. PMID 24730794 DOI: 10.1103/PhysRevE.89.032111  0.06
1984 Sykora KW, Kolitz J, Szabo P, Grzeschik KH, Moore MA, Mertelsmann R. Human interleukin 2 gene is located on chromosome 4. Cancer Investigation. 2: 261-5. PMID 6331870 DOI: 10.3109/07357908409018440  0.06
2019 Cazzell S, Moyer PM, Samsell B, Dorsch K, McLean J, Moore MA. A Prospective, Multicenter, Single-Arm Clinical Trial for Treatment of Complex Diabetic Foot Ulcers with Deep Exposure Using Acellular Dermal Matrix. Advances in Skin & Wound Care. PMID 31361269 DOI: 10.1097/01.ASW.0000569132.38449.c0  0.059
2011 Schwartz Z, Hyzy SL, Moore MA, Hunter SA, Ronholdt CJ, Sunwoo M, Boyan BD. Osteoinductivity of demineralized bone matrix is independent of donor bisphosphonate use. The Journal of Bone and Joint Surgery. American Volume. 93: 2278-86. PMID 22258774 DOI: 10.2106/Jbjs.J.01469  0.059
2016 David DJ, Anderson P, Flapper W, Syme-Grant J, Santoreneos S, Moore M. Apert Syndrome: Outcomes From the Australian Craniofacial Unit's Birth to Maturity Management Protocol. The Journal of Craniofacial Surgery. 27: 1125-34. PMID 27380568 DOI: 10.1097/SCS.0000000000002709  0.058
1983 Welte K, Venuta S, Wang CY, Feldman SP, Ciobanu N, Kruger G, Feickert HJ, Merluzzi VJ, Flomenberg N, Moore MA, Mertelsmann R. Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromes. Haematology and Blood Transfusion. 28: 369-79. PMID 6602744 DOI: 10.1007/978-3-642-68761-7_72  0.057
2013 Canaday CT, Moore MA, Tang W, Reynolds AP. Through thickness property variations in a thick plate AA7050 friction stir welded joint Materials Science and Engineering A. 559: 678-682. DOI: 10.1016/J.Msea.2012.09.008  0.057
2015 Moore MA. APJCP Loss of SCI Expanded Listing and the Future of the Journal. Asian Pacific Journal of Cancer Prevention : Apjcp. 16: 4145-6. PMID 26028063 DOI: 10.7314/APJCP.2015.16.10.4145  0.057
2015 Edelstein AI, Kwasny MJ, Suleiman LI, Khakhkhar RH, Moore MA, Beal MD, Manning DW. Can the American College of Surgeons Risk Calculator Predict 30-Day Complications After Knee and Hip Arthroplasty? The Journal of Arthroplasty. 30: 5-10. PMID 26165953 DOI: 10.1016/j.arth.2015.01.057  0.057
2009 McKimmie CS, Moore M, Fraser AR, Jamieson T, Xu D, Burt C, Pitman NI, Nibbs RJ, McInnes IB, Liew FY, Graham GJ. A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood. 113: 4224-31. PMID 19202130 DOI: 10.1182/blood-2008-08-174698  0.056
2014 Walters MS, De BP, Salit J, Buro-Auriemma LJ, Wilson T, Rogalski AM, Lief L, Hackett NR, Staudt MR, Tilley AE, Harvey BG, Kaner RJ, Mezey JG, Ashbridge B, Moore MA, et al. Smoking accelerates aging of the small airway epithelium. Respiratory Research. 15: 94. PMID 25248511 DOI: 10.1186/S12931-014-0094-1  0.055
2017 Bowl MR, Simon MM, Ingham NJ, Greenaway S, Santos L, Cater H, Taylor S, Mason J, Kurbatova N, Pearson S, Bower LR, Clary DA, Meziane H, Reilly P, Minowa O, ... ... Moore M, et al. A large scale hearing loss screen reveals an extensive unexplored genetic landscape for auditory dysfunction. Nature Communications. 8: 886. PMID 29026089 DOI: 10.1038/S41467-017-00595-4  0.053
1980 Ito M, Ralph P, Moore MA. Suppression of spleen natural killing activity induced by BCG. Clinical Immunology and Immunopathology. 16: 30-8. PMID 6991179 DOI: 10.1016/0090-1229(80)90163-4  0.053
2021 Snelling PJ, Keijzers G, Byrnes J, Bade D, George S, Moore M, Jones P, Davison M, Roan R, Ware RS. Bedside Ultrasound Conducted in Kids with distal upper Limb fractures in the Emergency Department (BUCKLED): a protocol for an open-label non-inferiority diagnostic randomised controlled trial. Trials. 22: 282. PMID 33853650 DOI: 10.1186/s13063-021-05239-z  0.052
2004 Pathak CP, Adams AK, Simpson T, Phillips RE, Moore MA. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential. Journal of Biomedical Materials Research. Part A. 69: 140-4. PMID 14999761 DOI: 10.1002/jbm.a.20129  0.051
2023 Snelling PJ, Jones P, Bade D, Bindra R, Davison M, Gillespie A, McEniery J, Moore M, Keijzers G, Ware RS. Diagnostic Accuracy of Point-of-Care Ultrasound Versus Radiographic Imaging for Pediatric Distal Forearm Fractures: A Randomized Controlled Trial. Annals of Emergency Medicine. PMID 37999655 DOI: 10.1016/j.annemergmed.2023.10.008  0.051
2012 Beyer F, Weigel M, Moore MA. One-dimensional infinite-component vector spin glass with long-range interactions Physical Review B - Condensed Matter and Materials Physics. 86. DOI: 10.1103/PhysRevB.86.014431  0.051
2012 Yeo J, Moore MA. Origin of the growing length scale in M-p-spin glass models. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 86: 052501. PMID 23214832 DOI: 10.1103/PhysRevE.86.052501  0.05
2014 Moore MA, Katzgraber HG. Dealing with correlated choices: how a spin-glass model can help political parties select their policies. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 90: 042117. PMID 25375448 DOI: 10.1103/Physreve.90.042117  0.05
1981 Moore MA. Genetic and oncogenic influences on myelopoiesis Hamatologie Und Bluttransfusion. 26: 237-242. PMID 6976288 DOI: 10.1007/978-3-642-67984-1_39  0.049
1974 Williams N, Moore MA, Shortman K, Condon L, Pike B, Nossal GJ. Density separation and characterisation of human blood leucocytes, including T and B lymphocytes. The Australian Journal of Experimental Biology and Medical Science. 52: 491-503. PMID 4547518 DOI: 10.1038/ICB.1974.48  0.048
1985 Arlin ZA, Mertelsmann R, Berman E, Gee T, Kurland E, Chaganti RS, Jhanwar SC, Moore MA, Clarkson BD. 13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 3: 473-6. PMID 3856630 DOI: 10.1200/JCO.1985.3.4.473  0.048
2006 Bull TM, Coldren CD, Nana-Sinkam P, Sotto-Santiago SM, Moore M, Voelkel NF, Geraci MW. Microarray analysis of peripheral blood cells in pulmonary arterial hypertension, surrogate to biopsy. Chest. 128: 584S. PMID 16373849 DOI: 10.1378/Chest.128.6_Suppl.584S  0.047
2019 Samsell B, McLean J, Cazzell S, Dorsch K, Moyer PM, Moore M. Health economics for treatment of diabetic foot ulcers: a cost-effectiveness analysis of eight skin substitutes. Journal of Wound Care. 28: S14-S26. PMID 31509489 DOI: 10.12968/jowc.2019.28.Sup9.S14  0.047
2010 Moore MA. A cancer fate in the hands of a samurai. Nature Medicine. 16: 963-5. PMID 20823875 DOI: 10.1038/nm0910-963  0.047
2016 Pun CB, Pradhananga KK, Siwakoti B, Subedi K, Moore MA. Malignant neoplasm burden in Nepal - Data from the seven major cancer service hospitals for 2012 Asian Pacific Journal of Cancer Prevention. 16: 8659-8663. DOI: 10.7314/APJCP.2015.16.18.8659  0.046
2015 Godfrey MJ, Moore MA. Understanding the ideal glass transition: lessons from an equilibrium study of hard disks in a channel. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 91: 022120. PMID 25768471 DOI: 10.1103/PhysRevE.91.022120  0.046
2011 Han MA, Choi KS, Park JH, Moore MA, Park EC. Midcourse evaluation of the second-term 10-year plan for cancer control in Korea. Asian Pacific Journal of Cancer Prevention : Apjcp. 12: 327-33. PMID 21517281  0.046
2013 Snell BJ, Flapper W, Moore M, Anderson P, David DJ. Management of isolated fractures of the medial orbital wall. The Journal of Craniofacial Surgery. 24: 291-4. PMID 23348303 DOI: 10.1097/SCS.0b013e3182710490  0.045
1979 Moore MA. Regulatory interactions in normal and leukemic myelopoiesis Hamatologie Und Bluttransfusion. 23: 171-180. PMID 232454 DOI: 10.1007/978-3-642-67057-2_21  0.044
2013 Walet NR, Moore MA. Nature of phase transitions in two-dimensional type-II superconductors Physical Review B - Condensed Matter and Materials Physics. 88. DOI: 10.1103/Physrevb.88.054513  0.044
2009 Hopkins RA, Jones AL, Wolfinbarger L, Moore MA, Bert AA, Lofland GK. Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep. The Journal of Thoracic and Cardiovascular Surgery. 137: 907-13, 913e1-4. PMID 19327516 DOI: 10.1016/J.Jtcvs.2008.12.009  0.043
2014 Williams-García RV, Moore M, Beggs JM, Ortiz G. Quasicritical brain dynamics on a nonequilibrium Widom line. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 90: 062714. PMID 25615136 DOI: 10.1103/PhysRevE.90.062714  0.043
2013 Larson D, Katzgraber HG, Moore MA, Young AP. Spin glasses in a field: Three and four dimensions as seen from one space dimension Physical Review B - Condensed Matter and Materials Physics. 87. DOI: 10.1103/Physrevb.87.024414  0.042
2015 Swan I, Reid M, Howe PW, Connell MA, Nilsson M, Moore MA, Morris GA. Sample convection in liquid-state NMR: why it is always with us, and what we can do about it. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 252: 120-9. PMID 25681799 DOI: 10.1016/J.Jmr.2014.12.006  0.042
2023 Ajmal Mokhtar SM, Yamada M, Prow TW, Moore M, Strudwick XL, Evans DR. PEDOT coated microneedles towards electrochemically assisted skin sampling. Journal of Materials Chemistry. B. PMID 37226634 DOI: 10.1039/d3tb00485f  0.042
2014 Zhu Z, Andresen JC, Moore MA, Katzgraber HG. Boolean decision problems with competing interactions on scale-free networks: equilibrium and nonequilibrium behavior in an external bias. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 89: 022118. PMID 25353433 DOI: 10.1103/Physreve.89.022118  0.041
2011 Vågberg D, Valdez-Balderas D, Moore MA, Olsson P, Teitel S. Finite-size scaling at the jamming transition: corrections to scaling and the correlation-length critical exponent. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 83: 030303. PMID 21517442 DOI: 10.1103/Physreve.83.030303  0.04
2018 Velardi E, Tsai JJ, Radtke S, Cooper K, Argyropoulos KV, Jae-Hung S, Young LF, Lazrak A, Smith OM, Lieberman S, Kreines F, Shono Y, Wertheimer T, Jenq RR, Hanash AM, ... ... Moore MA, et al. Corrigendum: Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury. Nature Medicine. 24: 525. PMID 29634695 DOI: 10.1038/Nm0418-525B  0.04
2013 Barnett-Jones M, Dickinson PA, Godfrey MJ, Grundy T, Moore MA. Transition state theory and the dynamics of hard disks. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 88: 052132. PMID 24329239  0.04
2003 Tarnowski CP, Stewart S, Holder K, Campbell-Clark L, Thoma RJ, Adams AK, Moore MA. Effects of treatment protocols and subcutaneous implantation on bovine pericardium: a Raman spectroscopy study. Journal of Biomedical Optics. 8: 179-84. PMID 12683843 DOI: 10.1117/1.1559729  0.039
2014 Moore MA, Vucetic JF. Identifying Effective IT Project Manager Personality Characteristics Proceedings - 2014 Annual Global Online Conference On Information and Computer Technology, Gocict 2014. 96-100. DOI: 10.1109/GOCICT.2014.28  0.038
2019 Moore BA, Leonard BC, Sebbag L, Edwards SG, Cooper A, Imai DM, Straiton E, Santos L, Reilly C, Griffey SM, Bower L, Clary D, Mason J, Roux MJ, Meziane H, ... ... Moore M, et al. Erratum: Author Correction: Identification of genes required for eye development by high-throughput screening of mouse knockouts. Communications Biology. 2: 97. PMID 30854487 DOI: 10.1038/s42003-019-0349-y  0.038
2012 Moore MA. Waking up HSCs: a new role for E-selectin. Nature Medicine. 18: 1613-4. PMID 23135509 DOI: 10.1038/nm.2992  0.037
2018 Nutter LMJ, Heaney JD, Lloyd KCK, Murray SA, Seavitt JR, Skarnes WC, Teboul L, Brown SDM, Moore M. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo". Nature Methods. PMID 29600991 DOI: 10.1038/Nmeth.4559  0.036
2012 Cobb AR, Moore M. Split plate technique in the fixation of remodelled cranial bones in infants. The British Journal of Oral & Maxillofacial Surgery. 51: 271-2. PMID 22766269 DOI: 10.1016/j.bjoms.2012.06.002  0.035
1981 Pelus LM, Broxmeyer HE, Moore MA. Regulation of human myelopoiesis by prostaglandin E and lactoferrin. Cell and Tissue Kinetics. 14: 515-26. PMID 7273093 DOI: 10.1111/j.1365-2184.1981.tb00557.x  0.035
2017 Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu H, Baker CN, Bower L, Brown JM, Caddle LB, Chiani F, ... ... Moore M, et al. Corrigendum: High-throughput discovery of novel developmental phenotypes. Nature. 551: 398. PMID 29144450 DOI: 10.1038/Nature24643  0.034
1991 Moore MA, Castro-Malaspina H. Immunosuppression in aplastic anemia--postponing the inevitable? The New England Journal of Medicine. 324: 1358-60. PMID 2017233 DOI: 10.1056/NEJM199105093241909  0.034
2012 Moore MA. 1/m expansion in spin glasses and the de Almeida-Thouless line. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 86: 031114. PMID 23030873 DOI: 10.1103/PhysRevE.86.031114  0.033
1997 Moore M, Feghali K, Gambarotta S. Preparation and Characterization of a Diamagnetic Sulfido-Bridged Divanadium Amide Complex. Inorganic Chemistry. 36: 2191-2194. PMID 11669843 DOI: 10.1021/Ic961471I  0.033
2022 Stallwood-Hall C, May A, Moore M. YouTube as a Source of Patient Education for Transcranial Craniosynostosis Procedures. The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association. 10556656221093292. PMID 35404171 DOI: 10.1177/10556656221093292  0.033
2011 Sun L, Chen JY, Negulescu II, Moore MA, Collier BJ. Kinetics modeling of dynamic pyrolysis of bagasse fibers. Bioresource Technology. 102: 1951-8. PMID 20855203 DOI: 10.1016/J.Biortech.2010.08.109  0.033
2010 Joyner-Grantham J, Simmons DR, Moore MA, Ferrario CM. The impact of changing ICD code on hypertension-related mortality in the southeastern United States from 1994-2005. Journal of Clinical Hypertension (Greenwich, Conn.). 12: 213-22. PMID 20433540 DOI: 10.1111/j.1751-7176.2009.00232.x  0.032
2000 Moore MA. Umbilical cord blood: an expandable resource. The Journal of Clinical Investigation. 105: 855-6. PMID 10749563 DOI: 10.1172/JCI9094  0.032
2016 Aspelmeier T, Katzgraber HG, Larson D, Moore MA, Wittmann M, Yeo J. Finite-size critical scaling in Ising spin glasses in the mean-field regime. Physical Review. E. 93: 032123. PMID 27078308 DOI: 10.1103/PhysRevE.93.032123  0.032
2015 Yeo J, Moore MA. Critical point scaling of Ising spin glasses in a magnetic field Physical Review B - Condensed Matter and Materials Physics. 91. DOI: 10.1103/PhysRevB.91.104432  0.03
2000 Barberi T, Moore MA. The LYL-1 oncoprotein is ubiquitously expressed in the mouse Experimental Hematology. 28: 45. DOI: 10.1016/S0301-472X(00)00229-0  0.03
1996 Moore MA, Leonard JP, Flasshove M, Bertino J, Gallardo H, Sadelain M. Gene therapy--the challenge for the future. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 53-8. PMID 8805950 DOI: 10.1093/Annonc/7.Suppl_2.53  0.029
2022 Snelling PJ, Jones P, Moore M, Gimpel P, Rogers R, Liew K, Ware RS, Keijzers G. Describing the learning curve of novices for the diagnosis of paediatric distal forearm fractures using point-of-care ultrasound. Australasian Journal of Ultrasound in Medicine. 25: 66-73. PMID 35722050 DOI: 10.1002/ajum.12291  0.029
2018 Velardi E, Tsai JJ, Radtke S, Cooper K, Argyropoulos K, Jae-Hung S, Jenq RR, Hanash AM, Moore M, Kiem H, Dudakov JA, Brink MRMvd. Suppression of Luteinizing Hormone Enhances HSC Recovery after Hematopoietic Injuries Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.688  0.028
2014 Moore MA, Lim MK, Huang X. Apologies for past mistakes and promises for a new start for the APJCP in 2014. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 1-2. PMID 24528006 DOI: 10.7314/APJCP.2014.15.1.1  0.026
2014 Vining AR, Boardman AE, Moore MA. The theory and evidence pertaining to local government mixed enterprises Annals of Public and Cooperative Economics. 85: 53-86. DOI: 10.1111/apce.12029  0.026
2018 Moore MA, Counce RM, Watson JS, Hall H. The Performance of two silica based ion exchange resins in the separation of Bi from its parent solution of Ac. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 141: 68-72. PMID 30179771 DOI: 10.1016/J.Apradiso.2018.08.020  0.024
2016 Moore MA, Coffman M, Jetty A, Petterson S, Bazemore A. Only 15% of FPs report using telehealth; Training and lack of reimbursement are top barriers American Family Physician. 93: 88.  0.024
1989 Moore MA. Cytokine networks in congenital, idiopathic and iatrogenic neutropenia International Journal of Radiation Oncology*Biology*Physics. 17: 110. DOI: 10.1016/0360-3016(89)90626-3  0.023
2011 Frates EP, Moore MA, Lopez CN, McMahon GT. Coaching for behavior change in physiatry. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 90: 1074-82. PMID 22019966 DOI: 10.1097/PHM.0b013e31822dea9a  0.019
2013 Glenton PN, Sutton JT, McPherson JG, Fittall ME, Moore MA, Heavysege RG, Box D. Hierarchical approach to facies and property distribution in a basin-floor fan model, Scarborough gas field, North West Shelf, Australia Society of Petroleum Engineers - International Petroleum Technology Conference 2013, Iptc 2013: Challenging Technology and Economic Limits to Meet the Global Energy Demand. 6: 4652-4666.  0.018
2015 Butteris SM, Schubert CJ, Batra M, Coller RJ, Garfunkel LC, Monticalvo D, Moore M, Arora G, Moore MA, Condurache T, Sweet LR, Hoyos C, Suchdev PS. Global Health Education in US Pediatric Residency Programs. Pediatrics. 136: 458-65. PMID 26260713 DOI: 10.1542/peds.2015-0792  0.017
2013 Barnett-Jones M, Dickinson PA, Godfrey MJ, Grundy T, Moore MA. Transition state theory and the dynamics of hard disks Physical Review E - Statistical, Nonlinear, and Soft Matter Physics. 88. DOI: 10.1103/PhysRevE.88.052132  0.017
2022 Moore M. Asian Pacific Craniofacial Association and Archives of Craniofacial Surgery. Archives of Craniofacial Surgery. 23: 51-52. PMID 35526838 DOI: 10.7181/acfs.2022.00122  0.015
2021 Diab J, Flapper W, Grave B, Abou-Hamden A, Anderson P, Moore M. The Many Faces of Sagittal Synostosis: A Novel Classification and Approach to Diagnosis. The Journal of Craniofacial Surgery. PMID 34387264 DOI: 10.1097/SCS.0000000000008086  0.011
2003 Meuris B, Phillips R, Moore MA, Flameng W. Porcine stentless bioprostheses: prevention of aortic wall calcification by dye-mediated photo-oxidation. Artificial Organs. 27: 537-43. PMID 12780508  0.01
2023 Snelling PJ, Jones P, Bade D, Bindra R, Byrnes J, Davison M, George S, Moore M, Keijzers G, Ware RS. Ultrasonography or Radiography for Suspected Pediatric Distal Forearm Fractures. The New England Journal of Medicine. 388: 2049-2057. PMID 37256975 DOI: 10.1056/NEJMoa2213883  0.01
2022 Moore M, Tator CH. Concussion Safety Law Should be Enacted in all Canadian Provinces and Territories. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-5. PMID 35189984 DOI: 10.1017/cjn.2022.12  0.01
2015 Moore MA, Huang X. Clarification of the APJCP editorial policy. Asian Pacific Journal of Cancer Prevention : Apjcp. 16: 2589-90. PMID 25854333 DOI: 10.7314/APJCP.2015.16.7.2589  0.01
2011 Moore MA, Wallace EC, Westra SJ. Chest trauma in children: current imaging guidelines and techniques. Radiologic Clinics of North America. 49: 949-68. PMID 21889016 DOI: 10.1016/j.rcl.2011.06.002  0.01
2010 Moore MA. The APJCP after ten years. Asian Pacific Journal of Cancer Prevention : Apjcp. 11: 1-2. PMID 20593914  0.01
Hide low-probability matches.